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ABSTRACT
Small diameter sensory nerves are implicated in the aetiology of inflammation; their
cell bodies are called dorsal root ganglia (DRG). Within 30min of induction of
unilateral tibio-tarsal joint inflammation by injection of Freund's Complete Adjuvant
(FCA) there is an increase in the mRNAs of p preprotachykinin-A (P PPT-A), which
encodes the sensory neuropeptides substance P and neurokinin A, and the a-
calcitonin gene-related peptide (CGRP) encoding gene, in DRG of innervating small
diameter nerves. The increases in both transcripts per small diameter neurones peaks
at lh, and is sustained at levels significantly above untreated controls up to 8 h after
injection. An increase in PPPT-A hetero-nuclear RNA, measured using a probe
complementary to a sequence to intron E, is seen within 30 min of FCA injection,
indicating the initial increase in mRNAs encoding this gene is at least in part due to
increased transcription. Increased expression per small neurone is augmented by an
increase in the proportion of small diameter cells expressing the mRNAs of both
PPPT-A and a-CGRP ipsilateral to FCA injection at lh, and maintained at
subsequent time points. Over the same time course the proportion of large diameters
neurones expressing PPPT-A and a-CGRP encoding mRNA did not change,
however increases of both transcripts per neurone increased within 30 min, peaking
at lh and returning to control levels at subsequent time points. It is possible that the
initial increases in transcripts per small and large diameter neurones are attributable
to a common molecular mechanism.
Previous experiments have implicated the transcription factor AP-2 in playing a role
in the inflammation-induced upregulation PPPT-A and a-CGRP. However the speed
of increases in transcripts coupled with the failure of the pre-administration of
cycloheximide to prevent the increases in a-CGRP encoding mRNA 30 min after
adjuvant injection indicates that increased transcription is independent of de novo
protein synthesis. Hence it is likely that the transcription/translation of immediate
early genes, such as AP-2 is not involved in the initial upregulation of (3PPT-A and
a-CGRP in response to FCA injection.
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Increases in mRNAs are initially mirrored in increases in the encoded peptides,
substance P and CGRP. Significant increases in both peptides occur within 30 min of
injection, peaking at lh. At subsequent time points peptides fall to control levels with
the exception of SP levels at 8h, which are significantly below control levels, this
may indicate increased axonal transport of peptide away from the DRG. The fast
increase in both gene expression and peptide levels, implicate SP, NKA and CGRP
in playing roles in the early aetiology ofFCA induced inflammation.
Within 15 min of injection of FCA around the knee joint there is an increase in
action potentials in innervating small diameter nerves within the range of the
response of polymodal C fibres to capsaicin application. Furthermore prior
administration of local anaesthetic around the sciatic nerve ipsilateral to adjuvant
injection prevented increases in expression of pPPT-A and a-CGRP mRNAs
suggesting that an increased neural activity in response to FCA injection may
underlie their upregulation.
In the first 8h of FCA induced inflammation, oedema formation and mechanical
hyperalgesia develop swiftly (within 30 min) with a progressive nature. However
infiltration by inflammatory cells is limited to the site of injection within 8h and up
to 24h after FCA administration. No changes were noted in bone, joint or synovial
tissue.
Application of phosphorothioate oligonucleotides increases production of SP and
CGRP in cultures of adult DRG neurones in a dose dependent manner, suggesting
stress may regulate expression of their encoding genes. The NFkB and STAT
families are two classes of transcription factors implicated in signalling stressful
stimuli. The are also capable of modulating rapid increases in gene expression due to
post-translational activation by phosphorylation. Analysis of the promoter regions of
both PPPT-A and the a-CGRP encoding gene revealed a number of sequences
sharing homology with NFkB binding sites, interferon-y activated site (GAS) and
interferon-stimulated response element (ISRE), the latter two are bound by members
of the STAT family. Western blot analysis revealed the presence of IxB-a, a member
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of the family ofNFkB inhibitors, in DRG extracts. By association members ofNFkB
family will also be present in DRG. Sequencing of PCR products generated from
cDNA derived from DRG mRNA and primers designed to amplify STATs 1, 3 and 4
demonstrated that STAT 1 is expressed in DRG. The activational state of either
STAT 1 or members of the NFkB family is unclear.
1: INTRODUCTION 1
1.1 Joint Inflammation: an overview 1
1.2 Sensory Nervous System 4
1.2.1 Innervation oftibio-tarsal joint 4
1.2.2 Sensory nerve population and distribution 5
1.3 Capsaicin 8
1.4 Neurogenic Inflammation 11
1.5 Neuropeptides in Sensory Nerves 13
1.5.1 Tachykinin family 13
1.5.2 Tachykinin receptors 15
1.5.3 Calcitonin gene-relatedpeptide 16
1.5.4 CGRP receptors 19
1.6 Action of SP, NKA and CGRP in SensoryNerves 19
1.6.1 Peripheral actions oftachykinins and CGRP 20
1.6.2 Central action oftachykinins and CGRP 25
1.7 Tachykinin Gene Expression 29
1.8 Regulation of PPT-A Expression 30
1.9 CGRP Expression 32
1.10 Messenger RNA and its Quantification 33
1.11 Transcription Factors in DRG 34
1.12 Neurotrophic andNeuropeptide Expression 37
1.13 Gene Knockout Studies 39
1.13.1 PPT-A knockout 39
1.13.2 NK1 knockout 39
1.13.3 Implication ofroles ofSP andNKA in inflammation 40
1.14 NFkB Family of Transcription Factors 41
1.15 The STAT Family of Transcription Factors 43
viii
1.16 Aims 47
2 MATERIALS AND METHODS 49
2.1 Induction of Joint Inflammation 49
2.2 Removal of L5 Dorsal Root Ganglia 49
2.3 In-situ Hybridisation 50
2.3.1 Solutions for in-situ hybridisation 50
2.3.2 Tissue sectioning 51
2.3.3 In-vitro transcription ofcomplementary riboprobes 51
2.3.4 Hybridisation and washing 52
2.3.5 Role ofprotein synthesis in increases in a-CGRP encoding transcripts 53
2.3.6 Statistics 54
2.4 Sub-cloning of Intronic Sequence of PPPT-A 54
2.4.1 Solutions 54
2.4.2 Generation of insert 55
2.4.3 Ligation of insert into pGEM3 56
2.4.4 Preparation ofcompetent bacteria 56
2.4.5 Transformations 56
2.4.6 Small scale preparation ofplasmidDNA 57
2.4.7 Large scale preparation ofplasmid DNA 57
2.5 Protein Levels of SP and CGRP after FCA Administration 58
2.5.1 Peptide extraction 58
2.5.2 Radioimmunoassy 59
2.6 The Role of Sensory Neural Activity in FCA Induced Joint Inflammation 59
2.6.1 Neural recordingsfrom small diameter sensory nerves 59
2.6.2 Reqidrement ofneural activityfor the increases in fPPT-A and a-CGRP encoding mRNAs 60
2.7 Progression of Inflammatory Indices 61
2.8 Histology of Tibio-tarsal Joints at Time Points After FCA Induced Joint Inflammation6 l
2.9 AntisenseOligonucleotides 62
ix
Cultures ofadult rat dorsal root ganglia 62
Radioimmunoassay 63
2.10 Western Blots 64
Solutions 64
Sample Preparation 65
2.11 Identification of STAT Transcripts in DRG by Reverse Transcription-Polymerase
Chain Reaction (RT-PCR) 66
Extraction ofRNA 66
Reverse transcription 61
Polymerase chain reaction (PCR) 67
Cloning ofPCR products 68
Sequencing ofcloned PCR products 68
3 PLASTIC CHANGES IN SYNTHESIS OF NEUROPEPTIDES IN SENSORY NERVES
FOLLOWING PERIPHERAL INFLAMMATION 70
3.1 Introduction 70
3.2 Results 73
3.2.1 fPPT-A and a-CGRP mRNA expression of in small diameter DRG neurones 73
3.2.2 fPPT-A and a-CGRP mRNA expression in large diameter DRG neurones 85
3.23 Levels ofsubstance P and CGRP in DRG 89
3.3 Discussion 91




4.2.1 Effect ofECA injection on neural activity 101
4.2.2 Role ofneural activity in plasticity in pPPT-A and a-CGRP gene expression 103
4.2.3 Progression ofinflammation, assessed as development ofoedema and mechanical
hyperalgesia 106
x
4.2.4 Changes ofhistology oftibio-tarsaljoints after adjuvant injection 108
4.3 Discussion 112
5 MOLECULAR MECHANISMS UNDERLYING NEUROPEPTIDE GENE
EXPRESSION 118
5.1 Introduction 118
5.1.1 Use ofantisense oligonucleotides to specifically inhibit gene expression 119
5.1.2 Transcriptionfactors and the expression ofneuropeptides 121
5.2 Results 122
5.2.1 Effect ofapplication ofAS-ON to sensory nerve cell culture to levels ofSP and CGRP 122
5.2.2 Identification ofputative transcription factor binding sites in the promoter regions ofrat
J3PPT-A and the a-CGRP encoding gene 126
5.2.3 IkB-ci in L5 ofuntreated and inflamed animals 130
5.2.4 Analysis ofSTAT gene expression in DRG by PCR 131
5.3 Discussion 134




1.1 Joint Inflammation; an overview
In humans, joints affected by injury or inflammatory articular diseases, such as
inflammatory or degenerative disorders, show hyperalgesia, a decrease in the pain
threshold and an exaggerated response to suprathreshold stimuli (Treede et al 1992),
and persistent pain in the joint area (Lewis 1938, 1942, Kellgren 1939, McEwen
1943, Obletz et al 1949, Kellgren and Samuel 1950). Hyperalgesia and pain are
aggravated by movement and mechanical stimulation of the affected limb (Kellgren
1939, McEwen 1943). The sensation of pain, termed nociceptive pain, is caused by
high intensity stimuli with potential to cause tissue damage.
Joint pain in humans can be created experimentally by application of noxious
mechanical, thermal and chemical stimuli to the fibrous structures of the joint,
ligaments and joint capsule (Lewis 1942, McEwen 1943, Kellgren and Samuel 1950).
The three major networks in the body, namely the immune system, endocrine system
and nervous system, are implicated in the development ofjoint inflammation. In order
to study the role of these systems in the pathogenesis of experimental joint
inflammation, there is a need for an in vivo system. As a result a number of animal
models of experimental joint inflammation have been developed with a view to
designing therapeutic strategies against inflammatory joint disorders.
Injection of urate crystals or kaolin and/or carrageenan into the cavity of a joint in
dogs, cats, rabbits, rats and pigeon causes an acute inflammation (Faires and McCarty
1962, Rosenthale et al 1966, Brune et al 1974, Schumacher et al 1974, Santer et al
1983, Okunda et al 1984, Schaible and Schmidt 1985, 1988, Schaible et al 1987,
Coderre and Wall 1987). Carrageenan injection causes the development of
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hyperalgesia in response to mechanical stimuli within l-3h (Santer et al 1983). In
addition there is formation of swelling, or oedema, caused by synthesis and release of
inflammatory mediators (Moncada et al 1979, Sedgwick and Willoughby 1985), and a
rapid response in the immune system, with cellular infiltration by polymorphonuclear
granulocytes at the site of inflammation (Santer et al 1983).
Rat models involving the injection of Freund's complete adjuvant (FCA), a
suspension of heat killed bacteria (typically Mycobacterium tuberculosis or M.
butyricum) have been used to study inflammation in joints. Injection of FCA into the
footpad, tailbase or lymph nodes instigates a two stage inflammatory reaction.
Initially there is a local acute inflammatory reaction within the first few hours of
injection, which subsides after 3-5 days. In the second week following injection
inflammation occurs in the distal joints of limbs, and also other sites in the body
including eyes, ears, tail and genitalia (Pearson 1963, Billingham and Davies 1979).
The inflammation subsides after 4 weeks but may recur spontaneously.
Observations that animals which have been subjected to whole body irradiation have a
delayed appearance of joint swelling (Wakeman 1960) suggest that the pathogenesis
of the disease has, at least in part, an immunological basis. Further investigation
suggested the aetiology of the model involves the immunogenic recognition of a
specific epitope of the mycobacterial 65kDa heat shock protein, hsp 65, causing
activation of host T-cells (Van Eden et al 1985). Bacterial hsp 65 shows a degree of
homology with mammalian heat shock protein 60, hsp 60, (Anderton et al 1995) and
also a self antigen in joint cartilage (Van Eden et al 1985). As a result, T-cells initially
activated against hsp 65 cross-react with host proteins, including cartilage
proteoglycans (Van Eden et al 1985), inducing an auto-immune disease state (Van
Eden et al 1989). Rheumatoid arthritis (RA) is also characterised by an auto-immune
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reaction, and FCA induced inflammation has been proposed as an animal model for
RA under the name adjuvant arthritis. There are a number of biochemical and
pathological similarities between RA and adjuvant arthritis, as summarised by
Rainsford (1982), although the absence of circulating rheumatoid factor in adjuvant
arthritis is perceived as weakness as a model for RA.
Study of the progression of adjuvant arthritis is complicated by the occurrence of
systemic effects including reduced weight gain (Pearson and Wood 1959), increased
vocalisation and irritability (Colpaert et al 1982), hyperventilation (Colpaert and Van
Hoogen 1983), reduced mobility (de Castro Costa 1987), as well as chronic pain
(Colpaert 1987) and activation of the hypothalamic-pituitary-adrenal axis (Sarlis et al
1992). By reducing the amount of mycobacteria injected it is possible to attain a less
severe arthritic condition, without the complicating effects of systemic disease (Butler
et al 1992). Injection of 100-150pg of mycobacterium into the foot pad or skin
overlying the tibio-tarsal joint leads to the development of a discrete monoarthritis
restricted to the injected joint. The monoarthritic state has also been referred to as
unilateral adjuvant-induced arthritis. Injection causes an acute inflammation at the site
of injection lasting between 2 and 4 weeks, but abolishes (Iadarola et al 1988 a and b)
or severely limits (Grubb et al 1991) the appearance of inflammation in distal joints.
The formalin test, first described by Dubuisson and Dennis (1977) is another model
for acute nociception and inflammation. Subcutaneous injection of diluted formalin
into the hindpaw of rats and mice produces a biphasic pain-related behavioural
response within the first hour after injection, accompanied by a long lasting
inflammation of the paw (Tjolsen et al 1992). The early phase, occurring immediately
after injection and lasting 5-10 min, is thought to be due to direct chemical
stimulation. The late phase, between 15 and 60 min post injection, is a result of
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inflammation. (Tjolsen and Hole 1997).
Work presented in this thesis employed FCA-induced unilateral inflammation of the
rat tibio-tarsal joint as described in Donaldson et al 1993.
1.2 Sensory Nervous System
The sensory nervous system has been implicated in playing a role in the aetiology of
inflammatory joint disease. This is based on the observation that in conditions
associated with a loss of innervation to a joint, such as poliomyelitis (Glick 1967) or
hemiplegia, (Thompson and Bywaters 1962) there is a resultant protection of the joint
from rheumatoid arthritis. Additionally hyperalgesia, swelling and joint destruction in
experimental inflammation in the rat induced by injection of M butyricum can be
attenuated by peripheral nerve section (Levine et al 1986), however a subsequent
study failed to find an attenuation of adjuvant arthritis after surgical
denervation(Ahmed et al 1995b).
1.2.1 Innervation of tibio-tarsal joint
Sensory innervation of the rat tibio-tarsal joint is provided by the tibial nerve, a
branch of the sciatic nerve. Sensory nerve fibres within the sciatic nerve are
pseudounipolar, having a peripheral branch innervating the joint and associated
structures, and a central branch, which enters the spinal cord at the dorsal tip of the
dorsal horn, branching and projecting to nuclei in the spinal grey matter and brain
stem (Greene 1959, Kelly 1991). The cell bodies, or somata of sensory neurones are
found in a structure known as the dorsal root ganglia (DRG). The cell bodies contain
the nucleus and organelles of the neurone, and are the site of production for a large
number of enzymes and bioactive peptides. The latter include neuropeptides, a class
of small peptides which are thought to act as neurotransmitters. Primary sensory
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nerves relay sensory information between the periphery and the central nervous
system.
The cell bodies of the sciatic nerve are located in the lumbar 4,5 and 6 dorsal root
ganglia, L4-L6 DRG, (Greene 1959). Only L5 DRG are solely innervated by the
sciatic nerve; L6 derived nerves also contribute to the make up of the pudendal
plexus, whereas L4 nerve fibres are found in obturator and femoral nerves (Greene
1959).
1.2.2 Sensory nerve population and distribution
The sciatic nerve contains a variety of groups or phenotypes of neurones, which have
been classified by a number of features as discussed below. Analysis of neuronal cell
bodies by diameter and staining the cytoplasm with Nissl stain has revealed 2 major
classes of DRG neurones; large light (A) and small dark (B) cells (Andres 1961).
However subsequent studies have shown that there is a size overlap between the light
and dark subpopulations (Lawson 1979, Lawson et al 1984). A refinement of the
division of primary sensory neurones has been proposed based on fibre diameter and
conduction velocity, this is summarised in table 1.1 below.
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Fibre Class Conduction Mean Cell Size Mean Cell
Velocity (m/s) ±SD (pm2) Diameter (pm)
Aa (la and b) >30 1171±410 39123
AP (II) 14-30 11041310 38120
Aa/p >14 11421366 38122
A5 (III) 2.2-8 7021448 30124
C(IV) <1.4 4491148 24114
Table 1.1 Classification of sensory nerve fibres in adult rat by their conduction
velocity from the sciatic nerve to the DRG, cross sectional area and diameter of DRG
neurone. The latter assuming that neurones are circular in cross section, from Harper
and Lawson (1985)
A8 and C fibres terminate as free nerve endings in various areas of the joint tissue; the
fibrous capsule, adipose tissue, ligaments, menisci, and periosteum (Samuel 1952,
Sklenska 1965, Frommer and Monroe 1966, Polacek 1966, Freeman and Wyke 1967,
Klineberg et al 1971, Halata et al 1984). Following an initial report describing free
nerve endings of A5 and C fibres in the synovial layer of joints (Polacek 1966)
subsequent studies failed to find them in this area (Samuel et al 1952, Freeman and
Wyke 1967, Halata et al 1984), however immunhistochemical studies from humans
have demonstrated the presence of free nerve endings in the synovium (Mapp et al
1990).
Electron microscope studies of free nerve endings in the cat knee joint capsule show
that A8 and C fibres form terminal trees (Heppleman et al 1990). These take on a
'string of beads' appearance with spindle-shaped thick segments (the beads)
connected by thinner segments. It is proposed that these beads and the end bulb of the
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nerve form the receptive sites of sensory endings.
Studies of response of the sensory innervation of the knee joint to innocuous and
noxious mechanical stimuli and chemical stimuli have identified different classes of
receptor units (Messlinger 1996). Units which respond to both mechanical and
chemical stimuli can be regarded as bimodal nociceptors, similar to polymodal
nociceptors found in cutaneous tissue (Lang et al 1990). Based on their response to
different mechanical stimuli articular afferents have be divided into groups: low-
threshold units, which respond to normal passive movements and high-threshold
units, which respond to noxious movements, or show no response to movement, but
do respond to pressure applied to the receptive field (Schaible and Schmidt 1983 a
and b, 1985). Studies of the conduction velocities of these two different classes of
units revealed that low threshold units are distributed throughout the range of
conduction velocities, being especially prevalent in the faster conducting nerves (AP).
The high threshold units belong to the classes of slow conducting nerves, implicating
A5 and C fibres in the transmission of noxious information.
Studies of the central terminals of sensory afferents in rat, cat and non-human
primates have shown that the different classes of fibres innervate different areas of the
spinal cord. A5 and C fibres terminate mainly in laminae I and II, although A8 also
innervate lamina III. Lamina III also receives input from Ap fibres, as does lamina IV
(Jessell and Dodd 1989).
Sensory neurones display a wide variety of different neurochemical markers.
Calbindin D28k, calcitonin gene-related peptide (CGRP), cholecystokinin (CCK) and
vasoactive intestinal peptide (Tuchscherer and Seybold 1985, Ju et al 1987, Villar et
al 1989, Antal et al 1990, Ishida-Yamamoto and Senba 1990, Noguchi et al 1990) are
found in both large and small cells. However other neurochemical markers are found
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in cell populations with more restricted size. Substance P (SP), somatostatin (SOM),
galanin, and fluoride-resistant acid phosphatase (FRAP) are usually found in small B
cells (Price 1985, Kai-Kai et al 1986, Ju et al 1987), whilst parvalbumin (PV),
carbonic anhydrase (CA) and GM1 ganglioside are restricted to large A cells (Wong
et al 1987, Robertson and Grant 1989, Antal et al 1990). Some of these markers are
widely distributed, for example CGRP is found in approximately 50% of DRG
neurones (Ju et al 1987), whereas other neurochemicals have far more limited
distributions, for example the neuropeptide galanin being only present in
approximately 5% of neurones (Villar et al 1989). Evidence has come to light of a
number of complex coexistence relationships between these markers, especially in
small cells. CGRP coexists with SP, SOM, CCK, galanin and FRAP (Ju et al 1987,
Gibbins et al 1987, Carr et al 1990). However these markers are not necessarily
colocalised with each other, for instance SP, SOM and FRAP are only rarely found in
the same populations of cells (Hokfelt et al 1976, Dalsgaard et al 1984, Price 1985)
It is probable that the distribution and coexistence of different markers defines
subpopulations of neurones, each with their own modalities. However the
relationships between the various markers remains to be resolved, making predictions
of the modalities of the different subpopulations of neurones difficult.
1.3 Capsaicin
Capsaicin (8-methyl-N-vanillyl-6-nonenamide), the active pungent extract from
chillies, causes a burning sensation when applied to the skin (Porszasz and Jansco
1959), but renders the excited nerves insensitive to further pain producing stimuli
(Jansco and Jansco-Gabor 1959, Jansco 1960, 1968). Systemic administration of
capsaicin in the neonatal rat resulted in the loss of 95% of C-fibres (Jansco et al
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1977). There is some contradictory evidence that at higher doses there is an effect on
AS fibres (Wall 1982, Nagy and Hunt 1983) and effects to the central nervous system
have also been reported (Fitzgerald 1983, Sivam and Krause 1992). However as a
result of the selectivity capsaicin shows for C-fibres capsaicin has been widely used
as a pharmacological tool to investigate the role of C-fibres in the development of
inflammation and processing of noxious stimuli. However, it should be noted that
there is a small population (5%) of C-fibres which are unaffected by capsaicin
administration.
Investigation into the effects of systemic capsaicin in adults rats established that
dorsal root ganglia were not destroyed, although there was a sensory deficit similar to
that seen in neonatal animals (Jansco 1968, Jansco-Gabor et al 1970, Joo et al 1969).
It has been suggested that this discrepancy may be due to capsaicin induced
destruction of sensory terminals, but not the cells bodies, evidence supporting this
theory comes from the observation that systemic capsaicin in the adult rat removes
99% of axons around the ureter, without affecting the number of axons in the
innervating dorsal roots (Chung et al 1985). Further research in the same laboratory
demonstrated that systemic capsaicin causes the loss of 93% of cutaneous
unmyelinated sensory axons, but does not induce the loss of axons in the area of the
innervating sural nerve (Chung et al 1990). This suggests that capsaicin-induced
neuronal death is limited to the terminal parts of cutaneous sensory axons. However
other observers have noted that systemic application of capsaicin in the adult causes a
marked loss of small diameter dorsal root ganglion cells, although the dose of
capsaicin required to cause this was twice as large (Jansco et al 1985). A consistent
feature in adult rats exposed to systemic capsaicin is the depletion of neuropeptides,
such as substance P, in central and peripheral terminals of small diameter sensory
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neurones (Gamse et al 1980, Jansco et al 1985, Priestley et al 1982, Jessell et al 1978,
Lynn 1990). A depletion of neuropeptides in response to capsaicin application has
also been reported in DRG cell cultures (Jeftinija et al 1992).
The selectivity of capsaicin in affecting a specific population of neurones has been
proposed as evidence for the existence of a specific capsaicin receptor. Recently a
receptor, termed VR1, has been cloned from a cDNA library constructed from DRG-
derived mRNA (Caterina et al 1997). Upon binding capsaicin, VR1 acts as a highly
permeable Ca2+ ion channel, fitting with evidence that capsaicin excites nociceptors
by increasing the permeability of the plasma membrane to cations (Bevan and
Szolcsanyi 1990, Oh et al 1996, Wood et al 1988) and the requirement for
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extracellular Ca ions in electophysiological desensitisation (Holzer 1991, Yeats et al
1992). Furthermore non-neuronal cells transfected with VR1 died upon continuous
exposure to capsaicin, consistent with the hypothesis that capsaicin-induced neural
death is a result of excessive ion influx (Bevan and Szolcsanyi 1990). Expression of
VR1 appeared to be limited to a subset of small diameter DRG neurones, (a much
smaller VR1 mRNA transcript was found in the kidney), explaining the selectively of
capsaicin for small diameter neurones. Additionally, not all small diameter neurones
expressed VR1, which may explain why neonatal capsaicin doesn't destroy all C-
fibres. Intriguingly, further evidence from cells transfected with VR1 suggests that a
• 2"b • n • • •sudden temperature increase causes a Ca influx, implicating the receptor as a
transducer of painful thermal stimuli in vivo.
In the arthritic rats, induced by injected ofM.tuberculosis around the tibio-tarsal joint,
subsequent sub-cutaneous injection of capsaicin caused a decrease in SP and CGRP in
DRG and SP in the joint, and caused a decrease in inflammation as measured by joint
weight (Ahmed et al 1995 a). Furthermore application of capsaicin to the innervating
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nerve of an arthritic joint attenuates the arthritic condition and prevents the spread of
arthritis to the contralateral limb in FCA induced bilateral arthritis (Donaldson et al
1995 a). This evidence implicates C-fibres and sensory neuropeptides in the
maintenance of experimental peripheral inflammation.
1.4 Neurogenic Inflammation
Neurogenic inflammation is the term coined to describe the involvement of the
nervous system in inflammation. The nervous system has been implicated as having a
role in inflammation since the observation published by Strieker in 1876 that
stimulation of the peripheral end of cut dorsal roots caused mild cutaneous
vasodilation, similar to that seen at the site of cutaneous inflammation. Further
experiments described the mediation of vasodilation by 'sensory afferent posterior
root-fibres', and suggested that this is due to 'impulses passing along sensory fibres in
a direction contrary to what is regarded as the usual one'. This phenomenon was
termed 'antidromic' (Bayliss 1901, 1923). The observation that neurogenic
inflammation in the eye caused by mustard oil application can be abolished by pre-
treatment with local anaesthetic or cocaine, or by degeneration of the trigeminal nerve
was used as evidence for an axon reflex underlying neurogenic inflammation (Bruce
1910). Inflammatory stimuli cause the triple response, an initial reddening at the site
of inflammation is followed by swelling (wheal), and thirdly a reddening of the tissue
spreading out from the site of injury (flare). Local anaesthesia of the skin prevented
the flare at the site of inflammation, the wheal being unaffected (Lewis 1927), this
observation was seen as evidence of a cutaneous network of sensory fibres mediating
the flare response. In this arrangement it was postulated that nerve terminals capable
of inducing vasodilation were situated around arterioles, distinct from cutaneous
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receptors which initiated the axon reflex. (Lewis 1927). However, blocking of action
potentials by tetrodotoxin injection did not prevent capsaicin induced plasma
extravasation at the site of application (Szolcsanyi 1984). Furthermore, the time
course of recovery of human skin from sensory desensitisation caused by capsaicin
application was identical for both efferent and sensory functions (Szolcsanyi 1988,
1991). This evidence has led to a revaluation of the axon-reflex theory of neurogenic
inflammation. It is now held that neurogenic inflammation is caused by
neurochemical release from the same sensory nerve fibres which detect the
inflammatory stimulus. As a result neurogenic inflammation can occur at the site of
injury without axon reflexes. However axonal conductance is thought to underlie the
development of flare away from the site of injection
Vasodilation and plasma extravasation due to release of active substances from
peripheral sensory nerves can be caused by stimulation of C-fibres in both the skin
(Jansco et al 1967) and cat knee joint (Ferrell and Russell 1986). Neurogenic
vasodilation and plasma extravasation can be impaired by prior desensitisation of the
skin administration by capsaicin application (Jansco et al 1967). Further experiments
have shown that capsaicin-induced impairment of neurogenic inflammation in the
skin is mirrored by a decrease of cutaneous SP content, implicating SP in the
development of neurogenic inflammation (Gamse et al 1980).
A number of mediators released in response to inflammatory stimuli either stimulate
or enhance the excitability of peptidergic sensory nerve fibres. These include
interleukin-ip (Fukuoka et al 1994), nitric oxide (Holthusen and Ardnt 1994),
prostanoids (Birrell et al 1991), protons (Steen et al 1992), bradykinin (Birrell and
McQueen 1993), histamine (Simone et al 1991) and 5HT (Blackshaw and Grundy
1993).
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1.5 Neuropeptides in Sensory Nerves
As previously discussed, a number of small peptides are found in sensory
nerves, which are implicated as neurotransmitters of sensory information. They are
produced in the neuronal cell bodies located within the dorsal root ganglia by
transcription of specific genes and translation of their resultant mRNAs., After
undergoing postranslational modifications, processed peptides are transported to
nerve terminals by axonal transport, and stored in vesicles. Neuropeptides are released
• 9+
in a Ca dependent manner upon depolarisation of the nerve terminal, and interact
with specific postsynaptic receptors. The neuropeptides of interest in this thesis are
members of the tachykinin family and calcitonin gene related peptide, their proposed
roles in inflammation and nociception are discussed below.
1.5.1 Tachykinin family
A number of neuropeptides share a common pentapeptide sequence at their carboxy-
terminal end, of Phe-X-Gly-Leu-Met-NH2, and are termed tachykinins. In mammals
the tachykinin family of peptides consists of Substance P (SP), Neurokinin A (NKA),
two N terminal extensions of NKA, Neuropeptide K and Neuropeptide y, and






Table 1.2 Amino acid sequence of members of the tachykinin family of
neuropeptides. Amino acids common to all three peptides are shown in bold.
Immunohistochemical studies show SP to be present in cat primary sensory neurones
(Hokfelt et al 1975), cell bodies of spinal ganglia (Hokfelt et al 1982) and the dorsal
horn of the rat spinal cord (Lembeck and Gamse 1982), implicating SP as a mediator
of signalling in primary sensory fibres. Depolarisation of peripheral sensory nerves by
electrical stimulation leads to SP release into the dorsal horn of the spinal cord (Yaksh
et al 1980). A number of neuropeptides, including SP have been shown to be involved
in synaptic transmission in autonomic ganglia (Hokfelt et al 1982) and antidromic
vasodilation, an important component of neurogenic inflammation (Olgart et al 1977,
Lembeck and Holzer 1979, Hokfelt et al 1982).
The levels of SP and its encoding mRNA, which also encodes NKA (see 1.7), have
been shown to be elevated in DRG innervating a rat tibio-tarsal joint injected with
FCA (Smith et al 1992, Donaldson et al 1992). In the streptozotocin-induced model of
diabetes in the rat there is a decrease in SP in DRG and joint synovium (Garrett et al
1995), reduced conduction velocity in unmyelinated nerves (Zochodne and Ho 1993),
decreased axonal transport of SP (Tomlinson et al 1988). Induction of inflammation
in the rat knee joint by injection of FCA in the streptozotocin-induced rat model of
diabetes produces a reduction in inflammatory response compared to non-diabetic
animals (Garrett et al 1996). This evidence implicates both SP and sensory nerves in
the development of the inflammatory response to FCA injection.
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1.5.2 Tachykinin receptors
Known receptors are termed NKi, NK2, nk3 and nk4. nk4 has only been recently
identified and little of its pharmacological profile is known (Donaldson et al 1996).
The other receptors are well defined and separated based on their varying affinities for
SP, NKA and NKB as shown in table 1.3.
EC50 (M)
nk, nk2 nk3
Substance P 3 x 10"9 8.7xl0"6 1.9xl0"7
Neurokinin A 5xl0"8 6xl0"8 2.9xl0"8
Neurokinin B 3.6xl0"7 3.4xl0"7 4.2xlO"10
Table 1.3 Affinity of tachykinins receptors for endogenous tachykinins, expressed as
concentrations of half maximal effect (ec50) on receptor subtypes expressed in
Xenopus oocytes (Otsuka and Yoshioka 1993).
Each of the tachykinins will bind to each of the neurokinin receptors, however there is
a degree of selectivity amongst the receptors. Thus, substance P is the selective
agonist for NKi, neurokinin A for nk2, despite having an equal affinity for NKi
receptors, and neurokinin B the selective agonist for nk3 receptors.
In the dorsal horn of the spinal cord NKi receptors are found primarily in laminae I
and II, areas which receives input from SP containing sensory nerves (Yashpal et al
1990). NK2 receptors are also found in the spinal cord, especially the dorsal and
ventromedial borders of the dorsal horn (Yashpal et al 1990). NKi and NK2 receptors
are found in a number of sites within the periphery, but particularly near blood
vessels. For example, NKi receptors are found on perivascular sites in human
synovium (Walsh et al 1992). Interestingly NKi receptors are reported to increase
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under inflammatory conditions, both peripherally at a number of vascular sites, at
lymph nodes and in rheumatoid synovium (Mantyh et al 1989, Garrett et al 1998) and
centrally in the dorsal horn (McCarson and Krause 1994). NK3 receptors are only
found in spinal cord, especially laminae I and II of the dorsal horn (Yashpal et al
1990). NKB the favoured ligand for NK3 receptors is also found in the dorsal horn
where it is reported to have an antinociceptive effect in the spinal cord (Laneuville et
al 1988). NKB is mostly derived from intrinsic spinal neurones (Ogawa et al 1985),
and the mRNA for the gene encoding NKB, preprotachykinin B, is absent from the rat
sciatic nerve and DRG (Moussaoui et al 1992).
1.5.3 Calcitonin gene-related peptide
Calcitonin gene-related peptide (CGRP) is a 37 amino acid peptide, two forms exist in
both humans and rats; a-CGRP, produced by alternative splicing of calcitonin gene
mRNA in neuronal tissue (as shown in fig 1.1) (Amara et al 1982), and (3-CGRP, the
sole product of a separate gene (Amara et al 1985). These two peptides are very


















Calcitonin Gene Related Peptide
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Neuronal Tissue
Figure 1.1 Calcitonin and calcitonin gene-related peptide (CGRP) are produced by
tissue specific alternative splicing of the same gene. Adapted from Amara et al 1982
CGRP is widely distributed throughout the central and peripheral nervous systems, in
both motor and sensory nerves, where the a-CGRP form is present. In rat sensory
nerves, CGRP has been shown to be colocalised with a number of other
neurotransmitters, including VIP, SOM, neuropeptide Y and especially SP (Ju et al
1987). This co-localisation suggests that CGRP rarely works on its own, and a role as
a neuromodulator has been suggested (Poyner 1992). Experiments involving
application of CGRP to myenteric neurones of guinea pig ileum showed that CGRP
induced the closure of potassium channels (Palmer et al 1986), causing a prolonged
increased excitability of the neurones. This is the mode of action of an enhancer of a
second depolarising stimulus, and indeed CGRP has been shown to act as an enhancer
in the rat dorsal horn, where prior administration of CGRP potentiated the responses
17
of substance P and noxious stimulation (Biella et al 1991). Additionally, intrathecal
CGRP increases the duration of the substance P-induced caudally directed biting and
scratching in rats and mice, without having any effect when administered alone
(Wiesenfeld-Hallin et al 1984). These two peptides have been shown to act together in
lowering the threshold of the nociceptive flexor withdrawal reflex in rats (Woolf and
Wiesenfeld-Hallin 1986). In addition CGRP can potentiate the release of substance P
from the dorsal horn neurones of the rat, suggesting a interaction with a presynaptic
receptor (Oku et al 1987) and can inhibit substance P degradation centrally and
peripherally (Le Greves et al 1985, Mao et al 1992).
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1.5.4 CGRP receptors
Lack of availability of selective non-peptide antagonists has clouded research into
CGRP pharmacology. CGRP receptors are classified as CGRPi and CGRP2
depending upon the different biological activity of CGRP analogues, especially
CGRP 8-37, which shows specificity for CGRPi receptors (Mimeault et al 1991).
Based on the selectivity for CGRP 8-37, the CGRPi receptor subtype are proposed to
be present in the dorsal horn of the spinal cord (Lofgren et al 1997). A third receptor
subtype is proposed in the nucleus accumbens (Van Rossum et al 1997).
1.6 Action of SP, NKA and CGRP in Sensory Nerves
During acute peripheral inflammation induced by injection of M. butyricum there is
an increase in density of neurones containing and releasing CGRP (Hanesch et al
1994) as well as an increases in CGRP in innervating DRG (Kuraishi et al 1989). SP
and its encoding mRNA are upregulated in DRG innervating joints inflamed by FCA
injection, a stimulus which also increases a-CGRP encoding mRNAs (Smith et al
1992, Donaldson et al 1992). The increase in mRNAs and peptide levels in DRG is
mirrored in increases in peptide levels released from sensory nerve terminals.
Immunoreactivity of SP, NKA and CGRP increases in the synovium of the knee joint
of rats with acute adjuvant induced monoarthritis (Bileviciute et al 1993).
There is also an increase in levels of SP in the dorsal horn of the spinal cord in FCA
induced polyarthritic rats (Oku et al 1987). CGRP release into the dorsal horn is
increased in FCA-induced polyarthritis (Collin et al 1993). SP and NKA has been
shown to be increased centrally in response to cat acute arthritis induced by
kaolin/carrageenan injection (Schaible et al 1990, Hope et al 1990).
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These data implicate sensory neuropeptides in the development of the inflammation,
both centrally and peripherally.
1.6.1 Peripheral actions of tachykinins and CGRP
An overview of the events underlying inflammation is described below (Fassbender
1994, Rang and Dale 1981). The first event in the inflammatory process is the
detection of damage, mediators released in response to this damage effect the local
capillary network and post capillary venules. Vasodilation of these blood vessels
causes increased blood flow to the inflamed area, which is evident in reddening of the
site of inflammation. The increased blood flow increases transport of components of
both the humoral (e.g. complement system) and cellular (e.g. neutrophils) defence
mechanisms, to the site of inflammation. Inflammatory mediators also increase
vascular permeability, allowing humoral factors to enter the inflamed tissue. Plasma
enters the tissue, via the enlarged gaps between the endothelial cells lining the
capillaries. The alteration in osmotic balance by the movement of plasma causes
inflow ofwater into the inflamed tissue, resulting in swelling (oedema). Inflammatory
cells also move from the blood vessels to the surrounding tissue, this movement is
regulated by the binding between cell surface ligands (adhesion molecules) expressed
by the endothelial cells lining blood vessels and cell surface receptors (intergrins)
expressed by inflammatory cells. Expression of adhesion molecules is regulated by
inflammatory mediators such as cytokines. Inflammatory cells actively migrate to the
site of inflammation in response to chemicals release (chemotactic stimuli). The first
cells to infiltrate the inflamed area are the granulocytes, including polymorphonuclear
leukocytes, followed by monocytes, macrophages and lymphocytes. Once at the site
of inflammation the inflammatory cells neutralise or remove the trigger of
inflammation.
20
Some of the interactions between immune cells, microvascular vessels and peripheral
neurones are outlined in figure 1.2. Additional events in the inflammatory process
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Figure 1.2 Summary of some of the interactions between the immune system, nervous
system and microvessels during inflammation. CGRP, calcitonin gene-related peptide;
COX-2, cyclooxygenase enzyme 2; 5-HT, 5-hydroxytryptamine (serotonin); IL-1, IL-
6 and IL-8 interleukin 1, 6 and 8 respectively; NGF, nerve growth factor; PGs,
prostaglandins; TNF-a, tumour necrosis factor a. Bi receptors refer to bradykinin
type 1 receptors. Modified from Dray and Bevan (1993).
1.6.1.1 Vascular effects of the tachykinins and CGRP
Release of tachykinins and CGRP cause increased blood flow in the rat knee joint
(Lam and Ferrell 1993), implicating these peptides in vasodilation of joint
microvasculature. Comparison of the vasodilator activity of these neuropeptides
revealed CGRP to be the most potent vasodilator, suggesting it to be the primary
mediator of vasodilation in neurogenic inflammation. The CGRP mediated
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vasodilation in skin is postulated to be as result of CGRP interaction with CGRPi
receptors (Brain 1996). Increased vascular permeability in the rat knee joint has been
shown to be primarily mediated by the action of SP at NKi receptors (Lam and Ferrell
1991, Hirayama et al 1993).
1.6.1.2 Neuropeptides in the development of primary hyperalgesia
Primary hyperalgesia occurs at the site of inflammation, it is due either to direct
activation of peripheral endings of sensory afferents in the region of inflammation, or
an indirect activation caused by the sensitisation of sensory nerve terminals. The latter
occurs during kaolin/carrageenan-induced inflammation in the cat knee joint
(Guilbaud et al 1985, Schaible and Schmidt 1985). As discussed in 1.4, activation or
sensitisation of peripheral sensory nerve terminals can be caused by a number of
inflammatory mediators, but is not thought to be a direct result of tachykinin or CGRP
action. However these neuropeptides can augment the inflammation, for instance SP
causes release of histamine from mast cells (Krumins and Broomfield 1993), which
then sensitises sensory nerves.
1.6.1.3 Interactions between the immune system and sensory neuropeptides
Inflammatory joint conditions, such as rheumatoid arthritis (Fassbender 1994) and
FCA induced inflammation (Donaldson et al 1993) are associated with infiltration of
inflamed tissue by cells of the immune system. SP, NKA and CGRP have been
implicated in modulation of inflammatory cell chemotaxis and function.
Neutrophils
This class of polymorphonuclear leukocytes (PMN) actively ingest invading
pathogens by phagocytosis and kills them by the action of oxygen metabolites such as
superoxide radicals (O2") and hydrogen peroxide. Lytic enzymes contained within
intracellular lysosomes then digest the pathogen. SP and CGRP are implicated in
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modulating the initial adherence of neutrophils to the endothelial lining of
microvessels as both neuropeptides cause neutrophil adherence to monolayers of
human endothelial cells (Zimmerman et al 1992). It also appears that SP has a
chemotactic effect on neutrophils, causing the accumulation of these immune cells.
The accumulation of neutrophils has been shown to be mediated by two different
mechanisms, either by NKi receptors in guinea-pig (Walsh et al 1995), or via the
activation of mast-cell in rat (Suzuki et al 1995), the latter pathway also causes the
accumulation of other leukocytes. SP also potentiates the production of superoxide by
human neutrophils (Serra et al 1994).
CGRP may also have a chemotactic effect, and is suggested to mediate the
accumulation of mouse neutrophils in response to IL-1 (Ahluwalia et al 1994).
Another potential role for CGRP is the activation of neutrophils, which has been
demonstrated in human neutrophils (Richter et al 1992).
Lymphocytes
Lymphocytes are the class of white blood cell which includes B and T cells which
mediate antigen-specific immune reactions. Both B and T cells have been implicated
in the aetiology of both rheumatoid arthritis and arthritic conditions induced by FCA
injection (Rainsford 1982). Experimental evidence suggests that SP causes
proliferation of human lymphocytes (Payan et al 1983). Conversely, CGRP appears to
have a down-regulatory role, inhibiting the following; mitogen-stimulated
proliferation of murine T-lymphocytes (Umeda et al 1988), production of interleukin
2 in mouse T lymphocytes (Wang et al 1992) and differentiation in the murine 70Z/3
pre-B lymphocyte cell line (McGillis et al 1993).
Other inflammatory cells
Experimental evidence suggests that SP and CGRP have effects on other
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inflammatory cells. SP causes the production of the inflammatory cytokines,
interleukins 1(3, 6 and 10 and tumour necrosis factor-a, in primed human monocytes
(Lieb et al 1996, Laurenzi et al 1990, Ho et al 1996) and the release of histamine from
mast cells (Krumins and Broomfield 1993). It has been also suggested that SP may
play a role in priming mast cells in rat (Janiszewski et al 1994). CGRP enhances
phagocytosis in cultured mouse macrophages (Ichinose and Sawada 1996), but
inhibits both the production of hydrogen peroxide and the ability of human
macrophages to present antigen (Nong et al 1989)
1.6.1.4 The role of the tachykinins and CGRP in tissue repair and wound healing
On removal or neutralisation of the trigger of inflammation, the inflammatory
reactions cease and repair processes take over. It has been suggested that
neuropeptides may act as cellular growth factors, playing a role in the tissue repair
and wound healing (Rosengurt 1991). SP has reported proliferative effects upon
human skin fibroblasts (Ziche et al 1990 a) and synoviocytes (Lotz et al 1987) and rat
smooth muscle cells (Payan 1985). There is evidence that SP and CGRP can exert
proliferative effects on human endothelial cells (Ziche et al 1990 b, Haegerstrand et al
1990) and that SP can induce the mobilisation of bovine capillary endothelium in
vitro (Ziche et al 1991). These observations suggested a role for SP in angiogenesis,
and this has been observed in vivo in the rabbit cornea (Ziche et al 1990 a).
Furthermore the survival of critical skin flaps in the rat is increased by application of
tachykinins and CGRP, implying these neuropeptides may have a role in wound
healing (Kjartansson et al 1987).
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1.6.2 Central action of tachykinins and CGRP
Terminals immunoreactive for SP are found in laminae I, II, V and X of the spinal
dorsal horn, areas where primary afferent nociceptive fibres terminate (Gibson et al
1981), and also in the laminae (I and II) with the highest density ofNKi receptors (see
section 1.5.2). SP is released into the spinal cord in response to a variety of stimuli
associated with nociception. These stimuli include excitation of C-fibres by electrical
stimulation (Yaksh et al 1980) or capsaicin application (Zhao et al 1992), and noxious
thermal, mechanical or chemical stimulation of the skin (Duggan et al 1988). Thermal
and mechanical stimulation of the hind paw at intensities above nociceptive
thresholds increases NKA and CGRP in the dorsal horn (Duggan et al 1987, Morton
and Hutchinson 1989). CGRP is also released into the dorsal horn upon electrical
stimulation of the sciatic nerve at intensities that activate C fibres (Klein et al 1990)
and in response application of the inflammatory mediators, bradykinin and
prostaglandins to the rat spinal cord (Andreeva and Rang 1993). These experimental
data suggest that SP, NKA and CGRP may be involved in the central response to
nociceptive input. Studies employing the specific NKj antagonist, CP 99,994, and
NK2 antagonist SR 48968 have provided evidence that both and NKi and NK2
receptors are involved in central transmission of nociception (Neugebauer et al 1996,
Sluka et al 1997). It has been suggested that NKi and NK2 receptors play different
roles in processing nociceptive information, for example it is appears that NK2
receptors are involved in the induction of heat hyperalgesia and NKi receptors in the
maintenance of heat hyperalgesia (Sluka et al 1997). Additionally intrathecal
administration of the CGRPi receptor antagonist, CGRP 8-37, results in decreased
nociception in thermally injured rats (Lofgren et al 1997).
Secondary hyperalgesia describes the state when hyperalgesia is observed at a site
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away from the initial inflammatory stimulus. For example, there is a decrease in paw
withdrawal latency in response to thermal stimuli within 4h and up to 24h after
kaolin/carrageenan injection into the rat knee joint (Sluka and Westlund 1993). It has
been suggested that there is a central contribution to secondary hyperalgesia observed
after hindpaw injection of carrageenan in rats (Guilbaud et al 1992). There is also a
reported enhanced excitability in spinal cord neurones in the kaolin/carrageenan
model of joint inflammation (Neugebauer and Schaible 1988) and adjuvant-induced
hindlimb inflammation (Hylden et al 1989), suggesting that the development of spinal
excitability may underlie secondary hyperalgesia. The role of SP, NKA and CGRP in
increased dorsal horn excitability is discussed below.
Activation of either low threshold Ap fibres or high threshold A5 and C fibres results
in increased aspartate and glutamate in the spinal cord (Kangrga and Randic 1991). In
non-inflamed conditions glutamate released from Ap fibres, activates AMPA
receptors, giving short lasting excitations (Dougherty et al 1992). Under non-inflamed
conditions glutamate binding at NMDA receptors has little effect due to blockage of
94- 94-
the ion channel in the by a Mg ion, preventing glutamate induced Ca influx. The
ion channel block is lifted in response to repeated C-fibre input into the rat dorsal
horn, resulting in NMDA receptor activation (Dickenson and Sullivan 1987, 1990).
As previously discussed neuropeptides are found in C-fibres, these include SP, 90%
of SP containing fibres also contain glutamate (Battaglia and Rustioni 1988). SP, as
well as NKA and CGRP, are reported to facilitate the effects of glutamate at NMDA
receptors in the slices of rat dorsal horn (Randic et al 1990, Kangrga and Randic
1990). It is proposed that the action of these neuropeptides on receptors in laminae I
and II sensitise the dorsal horn to input from the periphery (Woolf and Doubell 1994).
Stimulation of neuropeptide-containing small diameter afferents causes a slow post-
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synaptic potential in cat dorsal horn neurones, an effect which can be mimicked by
ionophoretic application of SP (Randic and Miletic 1977). On repeated stimulation of
small diameter rat afferents, slow post-synaptic potentials summate and cause
depolarisation of the postsynaptic membrane of the dorsal horn (Sivilotti et al 1993).
The depolarisation of the dorsal horn leads to a state of hyperexcitability and an
increased sensitivity to peripheral input, including low intensity inputs (Thompson et
al 1993). The hyperexcitability of the dorsal horn, also termed wind-up, can be
prevented by prior ionophoretic administration of the selective NKi receptor
antagonist, CP 96,345, suggesting SP may be involved in the aetiology of wind-up
(Neugebauer et al 1995). The cellular mechanisms underlying wind up are
summarised in figure 1.3
Wind-up results in increased sensitivity of the dorsal horn to the release of EAA from
both C and Ap fibres. This produces exaggerated responses to painful stimuli
(secondary hyperalgesia) and also the perception of previously innocuous stimuli as
painful. Dorsal horn sensitisation is reinforced by a phenotypic switch in a population
ofAp-fibres, which start expressing substance P (Neumann et al 1996).
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Figure 1.3 Cellular mechanism underlying central sensitisation and wind up. SP and
NKA released from C-fibres binds to specific receptors in the dorsal horn. SP and
NKA binding activates the IP3 signalling pathway (Nakajima et al 1992). The
resulting increased Ca2+ mobilisation causes protein kinase C (PKC) activation. The
NMDA receptor is phosphorylated by PKC, relieving Mg2+ block of the NMDA ion
channel. The lifting of the ion channel block sensitises the dorsal horn to further
release of glutamate and other excitatory amino acids, both from A (3 and C fibres.
Adapted from Woolf and Doubell 1994
The Ca2+ influx into the dorsal horn caused by glutamate binding to NMDA receptors
leads to an activation of cellular targets within the spinal cord, notably the induction
of the immediate early genes c-fos (Noguchi et al 1991), c-jun and NGFI-A
(Herdegen et al 1991) and activation of nitric oxide synthase (NOS). Nitric oxide,
produced by NOS, has been suggested in having a pro-inflammatory role in spinal
processing (Meller and Gebhart 1993).
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Experimental evidence presented in section 1.6 implicates the release of tachykinins
and CGRP from sensory nerves in multiple processes underlying inflammation.
Therefore, the control of the expression of genes encoding these neuropeptides is of
considerable interest and relevance to the aetiology of events in FCA-induced
inflammation.
1.7 Tachykinin Gene Expression
The levels of the tachykinins are dependent upon the expression of their encoding
gene. SP, NKA, and the related Neuropeptide K and Neuropeptide y, are encoded by
the gene preprotachykinin A (PPT-A). Alternative splicing of a common pre-mRNA
results in 4 different PPT-A mRNA transcripts, termed a,p,y and 8 as displayed in
figure 1.4 This leads to discrete expression of various peptide combinations in
different tissues. In DRG neurones mainly the p and y forms are present, as a result SP
and NKA are expressed in DRG neurones. Neurokinin B is encoded by a separate
gene, PPT-B, which is not expressed in DRG (Moussaoui et al 1992).
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Exon
Alternative Splicing Variants of the PPT-A Gene
a-PPT P-PPT
1 I 3 1 4 | 5 | 6 | 7
I I
y-PPT 5-PPT
2 | 3 [" 5 | 6 I 2 I 3 I 5
t I
Key: u '-i Substance P »«»i Neuropeptide K
i i Neurokinin A i i Neuropeptide y
Figure 1.4 Alternative splicing of PPT-A gene, which encodes substance P,
neurokinin A, neuropeptides K and y, leads to different splicing variants
Translation of the mRNAs leads to production of large precursor molecules. These
contain a signal peptide, directing the peptide to the correct cell compartment, the
individual tachykinins (separated by spacer sequences) and a carboxy terminal
sequence. The tachykinins are cleaved out of the precursor molecules by specific
enzymes, termed convertases, which typically cleave at doublets of basic amino acids.
The cleaved peptide then undergoes carboxy-terminal amidation, a step that is crucial
for substance P inflammatory action (Ogonowski et al 1997).
1.8 Regulation of PPT-A Expression
PPT-A expression will have a direct effect on the levels of SP available for
transmission of neural information. The mRNA levels of PPT-A increase in DRG
innervating a joint inflamed by injection of carrageenan (Iadarola and Draisci 1988),
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formalin (Noguchi et al 1988), or FCA (Donaldson et al 1993, Heppelmann et al
1993). Experiments carried out in cultures of sympathetic and sensory neurones have
shown that SP expression can be regulated by neurotrophic growth factors (Lindsay
and Harmar 1989), conditioned media (Nawa and Sah 1990, Nawa and Patterson
1990) and cytokines (Freiden and Kessler 1991, Shadiack et al 1993, Fann and
Patterson 1994). In vivo expression can be regulated in the striatum by cocaine (Hurd
et al 1992), and the hippocampus by depolarisation with kainate (Brene et al 1992),
whilst levels of SP in DRG are affected by glucocorticoids, (Smith et al 1991). It has
been suggested that these stimuli may act at the level of transcription (Paterson et al
1995 a).
The region 3.3kb 5' to the start point of transcription of the rat PPT-A gene is capable
of directing reporter gene expression in adult rat DRG neurones grown in culture
(Harmar et al 1993). Deletion analysis of this 3.3kb sequence has implied the
presence of two enhancer regions between -755 to -565 and +92 to +527 (the
transcriptional start point is designated as +1) (Mulderry et al 1993 a). Analysis of the
region 865bp 5' of the transcriptional start point has revealed a number of putative
transcription factor binding sites, including cAMP response elements (CRE) and AP1
and octamer binding sites (Carter and Krause 1990, Chapman et al 1993).
As discussed in section 1.2, DRG have a heterogeneous cell population, making the
obtainment of a homogenous nuclear extract for biochemical analysis difficult. The
non-neuronal HeLa cell line expresses a large array of transcription factors also
present in DRG neurones, including members of the octamer, AP-l(jun/fos), bHLH
(E box) and cAMP responsive element binding protein (CREB) families (Fiskerstrand
and Quinn 1996).
The region spanning -865 to + 500 has been studied using HeLa nuclear extracts and
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the techniques of DNAse 1 footprinting and electromobility shift assay (EMSA) in
order to identify the transcription factors which interact with this region in vitro.
Located in this region of the rat PPT-A gene are sites which interact with AP-1/CREB
(Paterson et al 1995a, Morrison et al 1995), octamer binding protein (Mendelson et al
1998), members of the bHLH (E box) family (Mendelson and Quinn 1995, Paterson
et al 1995 a,b and c) and the Sp 1 family (Quinn et al 1995, Mendelson et al 1998).
Interestingly within the enhancer regions active binding sites for octamer binding
proteins and members of the Sp 1 and NFkB families have been identified (Quinn et
al 1995, Fiskerstrand et al 1997, Mendelson et al 1998).
1.9 CGRP Expression
The control of CGRP gene expression has not been widely studied in neuronal cells,
however it has been shown that an enhancer element defined in thyroid cells spanning
the region -1127 to -957 can also stimulate promoter activity in neuroblastoma cell
lines (Stolarsky-Freedman et al 1990). NGF has been shown to increase CGRP and its
encoding mRNA up to 15 fold in cultured dorsal root ganglia, which were not
dependent upon NGF for survival (Lindsay 1988, Lindsay and Harmar 1989). Levels
ofmRNAs encoding CGRP in cultures of adult DRG are also increased by activators
of protein kinase A and protein kinase C (Supowit et al 1995). Subsequent studies
have determined enhancer regions necessary for the NGF-induced induction of a
minimal CGRP promoter transfected into cultures of adult DRG (Watson et al 1995)
and cAMP response element in the promoter region (Watson and Latchman 1995).
The NGF induced increase in CGRP mRNA observed in cultures of adult DRG can be
prevented application by the synthetic glucocorticoid, dexamethasone (Supowit et al
1995). CGRP mRNA has also been reported to be increased in neuronal cells by the
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application of activin A, a member of the transforming growth factor (3 superfamily of
cytokines (Fann and Patterson 1994).
1.10 Messenger RNA and its Quantification
The expression of specific genes can be investigated by quantifying the amount of
mRNA produced. The sequence of DNA is copied, or transcribed by RNA
polymerase enzymes in the cell nucleus. The rate of transcription is either facilitated
or inhibited by modulatory proteins known as transcription factors, which bind to
specific sequences of nucleotides within promoter regions of genes. The direct copy
of the DNA sequence containing sequences encoding protein (exons) separated by
non-coding regions (introns) is termed heterogeneous nuclear RNA (hnRNA). hnRNA
is a very short lived species the introns are rapidly spliced out and degraded, leaving a
mature mRNA containing only exons. Mature, spliced mRNA moves to the cytoplasm
where it can be translated at ribosomes into the encoded peptide.
mRNA (or hnRNA) can be quantified using in-situ hybridisation, which utilises a
synthesised oligonucleotide probe, complementary to the sequence of the mRNA of
interest. This complementary probe binds to the RNA species, and can be visualised
and quantified by a label, such as radioactive S-UTP. The advantage of in-situ
hybridisation over other techniques for quantifying mRNA is that synthesis can be
studied in specific locations, such as different cell sub-populations. In DRG there is a
heterogeneous cell population, the classification ofwhich is described in section 1.2.
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1.11 Transcription Factors in DRG
The activational state of transcription factors in DRG and their ability to bind to the
promoter region of PPT-A and the a-CGRP encoding gene are important in
understanding the upregulation of these neuropeptide encoding genes which appear to
underlie the aetiology of FCA induced inflammation.
Transcription factors can be broadly divided into 2 groups, those that are made de-
novo in response to a stimulus, for example the immediate early genes, and those
present in the cell which are activated by a post translational event such as
phosphorylation (reviewed by Jans 1995).
Previous analysis of the expression ofmRNAs encoding transcription factors in DRG
has shown that members of the AP-1 family of transcription factors, NGFI-A and
NGFI-B are either not present in DRG or their levels are unaltered in the first 8h after
FCA injection (Donaldson et al 1995 b). The AP-1 members, c-jun and junD have
been shown to be upregulated in DRG after sciatic nerve axotomy (Kenney and
Kocsis 1997), a condition characterised by a decrease in the expression of PPT-A and
a-CGRP encoding mRNAs (Verge et al 1995). Levels of mRNA encoding the
transcription factor AP-2 increase in DRG innervating an FCA inflamed tibio-tarsal
joint within lh of FCA injection (Donaldson et al 1995 b). Intriguingly EMSA
analysis has revealed an active AP-2 site in the promoter region of the rat PPT-A gene
between bases -865 and -47 (Quinn et al 1995), suggesting that AP-2 could regulate
PPT-A expression.
The involvement of those transcription factors made de novo, such as AP-2, in the
upregulation of neuropeptides following FCA induced inflammation, can be assessed
by inhibiting protein synthesis prior to FCA injection. Cycloheximide is a general
inhibitor of eukaryotic protein synthesis, inhibiting peptidyl transferase, the enzyme
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responsible for forming the peptide bond as detailed in figure 1.5. Given that
cycloheximide is a potent inhibitor of protein synthesis, and the vital role proteins
occupy in cell processes and metabolism necessary for cell survival, high doses of
cycloheximide are lethal. However work carried out studying the in vivo incorporation
of amino acid in rat liver and kidney have demonstrated that it is possible to inhibit
protein synthesis with a small, sub-lethal dose of cycloheximide (Rothblum et al
1976). A dosage of 3mg/kg administered systemically causes a 85% decrease in the
•2
incorporation of [ H] leucine within lh of intraperitoneal injection. This inhibition is
reversible, with incorporation returning to untreated levels at 48h.
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petidyl transferase tRNA 1 amino acids o
Figure 1.5 Diagram of elongation phase ofprotein synthesis in eukaryotes
1) Growing polypeptide chain attached by the terminal aminoacyl -tRNA
group to the P site of the ribosome. A site empty.
2) Binding of specific aminoacyl-tRNA molecule by hydrogen bonding at the
A site of the ribosome.
3) Peptide bond formed between the amino acid chain and the amino acid in
the P site. This is mediated by the action ofpeptidyl transferase.
4) The tRNA in the P site is ejected and the growing polypeptide chain
translocates from the A site to the now empty P site Thus the ribosome moves along
the mRNA, and the next amino-acyl tRNA complementary to the mRNA sequence
can enter at the empty A site (step 2)
Cycloheximide acts by inhibiting the actions of peptidyl transferase, preventing the
growth of the polypeptide chain and arresting protein synthesis. The mode of action is
non-selective, effecting all ribosomes, thus cycloheximide is a general inhibitor of
protein synthesis.
Adapted from Watson et al 1987
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1.12 Neurotrophins and Neuropeptide Expression
Nerve growth factor (NGF), a member of the neurotrophin family, has been shown to
be essential for survival of sympathetic and sensory neurones during development
(Thoenen and Barde 1980), and subsequently shown to positively regulate P-PPT A
and a-CGRP encoding mRNAs in cultures of adult dorsal root ganglia grown in the
absence of neuronal growth factors (Lindsay and Harmar, 1989). The identification of
NGF responsive elements in the promoter region of both PPT-A (Gilchrist et al 1991)
and the a-CGRP encoding gene (Watson et al 1995) and observations of the ability of
NGF to regulate neuropeptides genes in DRG in an in vivo situation (Amann et al
1996, Vedder et al 1993) have lead to a hypothesis that NGF is a mediator of plastic
changes in sensory neuropeptides during inflammation. Levels of NGF, produced in
smooth muscle cells, basal keratinocytes and fibroblasts, increases in the sciatic nerve
and peripheral tissue during experimentally (FCA) induced inflammation (Donnerer
et al 1992, Safieh-Garabedian et al 1995). It has been proposed that NGF transported
from the periphery to the cell body of the sensory nerve by retrograde axonal transport
causes an up-regulation in neuropeptide gene expression (Amman et al 1996). Indeed
in rats with transected peripheral nerves, a situation which would abolish retrograde
axonal transport, including that of NGF from the periphery to DRG, there is a
decrease in the synthesis of SP and CGRP, which can be reversed by NGF
administration (Verge et al 1995). The rate of retrograde NGF transport in the rat
sciatic nerve has been measured at 13 mm/h (Stockel et al 1975). As a result it would
take several hour between the production ofNGF in the periphery and effects ofNGF
on neuropeptide gene expression in DRG.
Other members of the neurotrophin family include brain derived neurotrophic factor
(BDNF), neurotrophin 3 (NT-3) and neurotrophin 4 (NT-4). The latter is also known
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as NT-4/5 or NT-5. BDNF has been reported to induce preprotachykinin expression in
the central nervous system (Croll et al 1994, Nawa et al 1994). However neither
BDNF or the related neurotrophin 3 (NT-3) induce PPT-A expression in adult DRG
neurones, both in-vitro (Mulderry 1994) and in-vivo (Zhang et al 1995).
Using in situ hybridisation PPT-A and a-CGRP have been shown to be co-localised
in small diameter (< 25pm) nerve fibres with the high affinity NGF receptor, trkA
(Kashiba et al 1996). The high affinity receptors for BDNF (trkB, which also bind
NT-4) and NT-3 (trkC) are found in DRG neurones, but are not co-expressed with the
mRNA encoding PPT-A, although a very small number of neurones expressed both
trkC and a-CGRP transcripts (Kashiba et al 1996). It should be noted that this study
demonstrated that not all neurones positive for PPT-A or a-CGRP mRNA also
expressed high affinity neurotrophin receptor mRNAs. These neurones include a
subpopulation of small diameter cells and all large diameter cells expressing PPT-A
mRNA. Additionally not all trkA mRNA positive cells also expressed PPT-A or a-
CGRP encoding mRNAs.
The low affinity neurotrophin receptor, p75, which binds all members of the
neurotrophin family, is also expressed in DRG neurones, in fibres of all diameters.
Expression of p75 is limited to cells expressing one of the trk high affinity
neurotrophin receptor subtypes (Wright and Snider 1995), fitting with p75's proposed
role of regulating trk signalling (Verdi et al 1994). However, recent experimental
evidence that binding of NGF to p75 causes the activation of the transcription factor
NFkB in Schwann cells (Carter et al 1996) suggests that the p75 receptor may play a
role in signalling independently of high affinity trk receptors. The precise relationship
between p75 and PPT-A/CGRP expressing DRG neurones has not been studied.
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1.13 Gene Knockout Studies
Recently mutant mice have been generated with targeted deletion of the SP and NKA
coding regions of PPT-A (Cao et al 1998) or the gene encoding NKi receptors (De
Felipe et al 1998), with the aim of elucidating the role of SP and NKA in
inflammation and pain transmission.
1.13.1 PPT-A knockout
Mice with a disrupted PPT-A gene show similar responses to mildly painful stimuli as
wild type mice, but the responses to moderate to intense thermal, mechanical or
chemical pain are significantly decreased. However at very high intensities of pain,
wild type and homozygous knock-out mice displayed similar responses, thus
suggesting that SP and NKA are involved in the transmission of painful stimuli within
a specific range or window. Capsaicin specifically activates C fibres (see section 1.3),
greatly decreased plasma extravasation and oedema formation in response to
capsaicin in homozygous mutants compared to wild type mice, implicates SP release
from C fibres as pivotal to these responses. However this hypothesis is complicated
by the fact that heterozygous animals also display decreased plasma extravasation and
oedema in response to capsaicin. FCA injection causes development of oedema and
allodynia (decreased nociceptive threshold) to a similar degree in both wild type and
mutant mice, suggesting that these events are not solely dependent on SP. As depicted
in figure 1.2 other substances produced in response to inflammation have been
implicated in the development of inflammatory processes.
1.13.2 NKI knockout
The NKi receptor shows highest affinity for substance P, mutant mice lacking this
receptor sub-type did not display a graded response to increasing electrical and
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mechanical stimulation, nor did they display 'wind up'. Mutant mice also showed
decreased neurogenic inflammation in response to capsaicin and carrageenan,
although after FCA injection mutant mice displayed oedema, erythrema and
mechanical hyperalgesia similar to that seen in wild type mice.
1.13.3 Implication of roles of SP and NKA in inflammation
The similarity of behaviour and inflammatory responses in both mutant animals
suggests that neither SP or NKA is the primary transmitter of painful stimuli, with
glutamate being the most likely candidate for this role. SP and NKA are implicated as
having facilitatory roles aiding glutamate transmission in dorsal horn upon release in
response to stimuli of a specific intensity of stimuli. This proposed role for SP and
NKA agrees with the evidence presented in section 1.6.2 for a role for these
tachykinins in 'wind-up'. The similarity between the two different mutants suggests
that the central actions of the tachykinins are mediated primarily via the NKi receptor
subtype. It is interesting to note that peripheral inflammatory events attributed in part
to the action of SP and NKA, such as oedema formation, still occur in both mutant
mice. Many different mediators play modulatory roles in inflammation (see figure
1.2), some of these mediators are reported to have similar actions to SP or NKA, for
instance bradykinin, histamine and 5-HT are known increase vasodilation and
permeability of the microvasculature (Rang and Dale 1991). It is likely that other
mediators take over the role of SP and NKA in the absence of these neuropeptides or
the lack of NKi receptors. Interestingly both PPT-A knockout and NKj receptor
knockout mutant mice have similar patterns and densities of immunohistochemical
staining for CGRP in the spinal cord wild type mice (Cao et al 1998, De Felipe et al
1998), a neuropeptide which has been demonstrated to mediate an number of
inflammatory events (see section 1.6).
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SP and NKA are widely expressed throughout both the peripheral and central nervous
system, as well as in non-neuronal cells of neural crest origin, such as pituitary
(Brown et al 1991), adrenal glands (Kuramoto et al 1985), thymus (Ericsson et al
1990), leydig cells (Chiwakata et al 1991) and eosinophils (Weinstock et al 1988). In
mutant mice with a disrupted PPT-A gene, the loss of SP and NKA occurs throughout
the body and is not localised to primary sensory nerves. Additionally the evidence that
tachykinins have a role in proliferation of endothelial cells (Ziche 1990 b, Rosengurt
1991) suggest that they may play a role in development. As a result it can not be
certain that the differences between mutant and wild type mice are solely due the loss
of SP in sensory nerves, but may reflect a deficiency in a system contributing to the
transmission of pain transmission and the development of inflammation.
1.14 NFkB Family of Transcription Factors
NFkB was first described as a nuclear factor capable of binding to the enhancer of the
gene encoding the k light chain of antibodies in B cells (Sen and Baltimore 1986).
Since its initial discovery it has been found in a large number of cell types including
neuronal and glial cells (Meberg et al 1995, O'Neill and Kaltschmidt 1997). Cloning
studies have also shown the existence of at least 5 members of the NFkB family in
mammals, namely p50, p52, p65 (also known as RelA), RelB and c-Rel. (Baeuerle
and Baltimore 1996). Members of the NFkB family exert their effects on gene
transcription by binding to genes in different combinations of hetero- and
homodimers. Comparison of NFkB binding sites in inducible genes has led to the
proposal of the consensus sequence of kB binding, ofGGGAa/cTNt/cCC (Faisst and
Meyer 1992). In an inactive state NFkB dimers are found in the cytoplasm complexed
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to an inhibitory protein termed IkB, of which there are 5 different forms in mammals
termed a, p, y, 5 and s. The most common cytoplasmic complex is a heterodimer of
p50/p65 bound to IkB-oc. Phosphorylation of IkB-oc at two serine residues (at
positions 32 and 36) leads to ubiquitination and subsequent proteolytic degradation of
IkB-cc, unmasking the nuclear localisation signal ofNFkB (Zabel et al 1993, Beg et al
1992). This allows the dimer to translocate to the nucleus and regulate gene
transcription. This pathway is described in figure 1.6.
A number of protein kinases have been reported to cause the phosphorylation of IkB
in vitro, including protein kinase C, PKA and casein kinase (Ghosh and Baltimore
1990), however doubt has been cast on the putative in vivo roles of these kinases.
However a cytokine-responsive IkB kinase has been purified from HeLa cells treated
with tumour necrosis factor a (TNF-a), which shows substrate specificity and
kinetics of activation which correlated well with IkB-o. phosphorylation in living cells
(Di Donato et al 1997).
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Figure 1.6 Activation ofNFKB by phosphorylation induced degradation of ItcB
1) NFkB dimer is sequested in the cytoplasm bound to IkB. Phosphorylation of IkB
occurs at specific serine residues in response to extracellular stimuli.
2) Phosphorylated IkB is ubiquinated by ubiquitin conjugating enzymes.
3) Ubiquitin labelling marks IkB for degradation by proteasome. Degradation of IkB
unmasks the nuclear localisation sequence of NFkB, allowing translocation to the
nucleus
4) Once in the nucleus NFkB can influence the transcription of genes with recognition
sequences in their promoter regions.
Adapted from Baeuerle and Baltimore 1996
1.15 The STAT Family of Transcription Factors
Studies have shown the transcription of a number of genes is increased within minutes
of application of interferon a and y to cultured cells (Friedman et al 1984, Larner et al
1984). This transcriptional activation is mediated via a novel signalling pathway,
central to which are janus kinases (Jak) and signal transducers and activators of
transcription (STAT). This pathway is described in figure 1.7.
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Figure 1.7 The Jak/STAT pathway
1) Jak/Stat associated receptors consist of la and lp subunit, ligand binding induces
receptor dimerisation
2) Dimerisation of the receptor brings associated Jak kinases into apposition, enabling
a) reciprocal transphosphorylation and b) phosphorylation of a distal tyrosine on the P
subunit of the receptor
3) The phosphorylated receptor residue is recognised by the SH-2 domain of a STAT
protein, drawing them into the receptor complex, where they are activated by tyrosine
phosphorylation
4) The activated STAT proteins form hetero- or homo- dimers which translocate to
the nucleus, binding to specific sequences ofDNA and modulating transcription.
In this scheme the Jaks can be identical or different, as can the STATs. Modified from
Schindler and Darnell (1995).
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In mammals there are 4 identified members of the Jak family, Jakl, 2 and 3, and
Tyk2, (Ihle and Kerr 1995) which are associated with the cytoplasmic domain of the
a subunit of the receptor. Binding of ligand at the associated receptor causes
phosphorylation of Jaks at specific tyrosine residues and results in activation of kinase
activity (Schindler and Darnell 1995). One of the targets for phosphorylation by
activated Jaks are the STAT family of transcription factors. At present 7 STAT
proteins have been identified in mammals; namely STAT 1, 2, 3, 4, 5a, 5b, 6, which
show a large degree of intra-family sequence homology (Schindler and Darnell 1995).
The highest area of conservation is in a region near the carboxyl terminus, called the
SH2 domain, which is virtually identical to the SH2 domain of the src kinase family
(Ihle and Kerr 1995).
Adding further complexity to the STAT family, two forms of STAT 1 have been
identified, encoded by a single gene, an 84 kDa protein (STAT la) and a 91 kDa
protein, (STAT ip) (Schindler et al 1992).
Phosphorylation at specific tyrosine residues allows STAT dimerisation and nuclear
translocation (Figure 1.6), Mutation of the tyrosine residue at position 701 of STAT 1
prevents its translocation to the nucleus (Gutch 1992). Activated STATs translocate
to the nucleus as either hetero- or homodimers capable of binding DNA and activating
transcription (Shuai et al 1993, Zhong et al 1994). For example the transcription
factor ISGF-3 has been identified as containing STAT 2, either STAT la or 1P, and a
48 kDa protein and (Fu et al 1990). Comparison of the promoter region of genes
regulated by interferon a or y revealed that binding occurs at specific sequences of
DNA. Genes stimulated by addition of interferon y contain interferon y activation sites
(GAS), whilst genes stimulated by the addition of interferon-a contain interferon-a
stimulated response elements (ISRE). The consensus of these sequences are
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characterised in table 1.3.
Interferon y activation sites (GAS) TTNCNNNAA
Interferon-a stimulated response elements (ISRE) AGTTTCNNTTTCNc/t
Table 1.3 Consensus sequences of DNA binding sites for STAT proteins, based on
Darnell et al 1994.
Further research has demonstrated that the Jak/STAT pathway can be activated by a
wide variety of cytokines, growth factors and hormones (Schindler and Darnell 1995).
Given the complexity of other signalling pathways it is conceivable that some degree
of cross-talk with other signalling molecules could occur, indeed the glucocorticoid
receptor (GR) has shown to act synergistically with STAT 5 at the level of
transcription (Stocklin et al 1996).
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1.16 Aims
Previous studies from the laboratory have used a model of unilateral tibio-tarsal joint
inflammation induced by sub-dermal injection of 0.15ml FCA. This stimulus causes
an increase in mRNAs from PPPT-A and the a-CGRP encoding gene in ipsilateral
small diameter L5 DRG neurones as early as 8h after FCA, no changes occur in
contralateral small diameter DRG neurones. The ipsilateral increases are prevented by
administration of local anaesthetic around the innervating sciatic nerve prior to FCA
injection, suggesting that neural activity may underlie the increases in neuropeptide
encoding mRNAs. Initial investigations into putative molecular mechanisms involved
in the ipsilateral increases in the expression of PPT-A and the a-CGRP encoding gene
have found that mRNA encoding AP-2 increases in L5 DRG lh after FCA injection.
Using the FCA induced model of unilateral tibio-tarsal joint inflammation. The aims
of work presented in this thesis are as follows:
1) To study the time course of the levels of mRNAs encoding PPT-A and a-
CGRP over the first 8h and to ascertain the possible roles of AP-2 and NGF in the
increases in mRNAs seen by 8h after FCA injection.
2) To investigate whether the increases in mRNA is reflected in an increases
in hnRNA and hence de novo gene expression.
3) To explore the time course of levels of SP and CGRP in L5 DRG, to see if
they reflect increases in their encoding mRNAs.
4) To investigate changes in neural activity in sensory nerves after FCA
injection, and the requirement for neural activity in the increases in pPPT-A and a-
CGRP mRNAs.
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5) To examine the development of inflammation over the first 8h after FCA
injection, measured by oedema formation, mechanical hyperalgesia and histological
changes in the area of injection.
6) To identify putative molecular mechanisms underlying the increased
expression of the PPPT-A and a-CGRP encoding genes
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2 Materials andMethods
All chemicals and solvents used were of analytical grade and were obtained from
BDH Chemicals Ltd, Poole, UK or Sigma Chemicals Ltd, Poole, UK, unless
otherwise stated. Enzymes and their respective buffers were obtained from Promega
Ltd, Southampton, UK unless otherwise stated.
2.1 Induction of Joint Inflammation
Unilateral joint inflammation was induced in male Han-Wistar rats (200-300g) by
intra-dermal injection at two sites around the left tibio-tarsal joint with 0.15ml of
lmg/ml Freund's Complete Adjuvant (FCA) containing 150pg M. tuberculosis,
whilst under 4% halothane anaesthesia. Control animals received no injection or
0.15ml sterile saline injected as described for FCA.
2.2 Removal of L5 Dorsal Root Ganglia
Animals were killed by CO2 inhalation, at specific time points and L5 DRG
innervating the limb ipsilateral and contralateral to injection were identified by
tracing the sciatic nerve, which branches into DRG L4-6. DRG were removed by
laminectomy, snap frozen on dry ice and stored at -80°C
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2.3 In-situ Hybridisation
2.3.1 Solutions for in-situ hybridisation
Diethyl pyrocarbonate (DEP) water
4% Paraformaldehyde





Box Buffer (for hybridisation)
RNase Buffer
TBE(lOx)
4% Polyacrylamide gel for electrophoresis
0.02% DEP in distilled water, leave to
stand for 2 hours and sterilise by
autoclaving
20mM NaH2P04, 80mM Na2HP04, 40g
paraformaldehyde in 1 litre DEP water
3M NaCl, 0.3M trisodium citrate
50ml RNase free 20xSSC diluted with
450 ml DEP water
1.2M NaCl, 20mM Tris-Cl (pH 7.5),
2mM EDTA, 20% (w/v) dextran
sulphate, 2xDenhatrs, 0.2mg/ml salmon
sperm DNA, 0.25mg/ml yeast tRNA
(Gibco BRL Life Technologies Ltd,
Paisley, UK)
Mix 15 g Amberlite ion exchange resin
with 150 ml formamide for 1 hour at
room temperature and filter.
50% deionised formamide, 20%
20xSSC, 30% DEP water
0.5M NaCl, 0.01M Tris-Cl, O.OlmM
EDTA
108.9g Tris base, 55.7g boric acid, 4.7g
EDTA made up to 1 litre
3.6g Urea, 1.32ml 40% acrylamide:bis-
acrylamide (19:1), 1ml lOxTBE,
distilled water to 10ml. Polymerise with






lOmM Tris-HCl (pH 8.0), ImM EDTA
1% w/v agarose in 0.5xTBE, dissolved
by heating in microwave oven and
1 pg/ml of ethidium bromide added
2.3.2 Tissue sectioning
Glass microscope slides were prepared for tissue mounting by 3 minute washes in
each of 0.2M HC1/DEP water, DEP water, and acetone and drying in an oven at
60°C. Slides were then coated in a subbing solution of 0.15% gelatin, 0.03% sodium
azide in DEP water for 5 minutes, dried and then coated in 0.2% poly-L-lysine in
DEP water. DRG sections were cut to 10pm thickness using a -20°C Cryostat (Bright
Instrument Company Ltd, Huntingdon, UK), and mounted on subbed glass
microscope slides. Cut sections were stored at -80°C.
2.3.3 In-vitro transcription of complementary riboprobes
Plasmid constructs containing cDNA template sequences encoding pPPT-A (454bp
full length cDNA a kind gift from Prof A.J. Harmar, cloned into pGEM3 (Promega))
and a-CGRP (450bp fragment encoding 3' untranslated sequence a kind gift from Dr
S. Amara, cloned into pSP64) were linearised by digestion with the restriction
enzyme EcoRl to allow in vitro transcription as follows; lOpg plasmid in TE (pH8),
2 units EcoRl, lx EcoRl reaction buffer (90mM Tris-HCl, 10 mM MgCE, 50mM
NaCl), 28pl DEP water. Digestion was carried out at 37°C for lh, and complete
digestion and hence linearisation verified by electrophoresis on a 1% agarose gel in
0.5xTBE buffer. DNA was visualised on a UV transilluminator.
Linearised templates were incubated in a total volume of lOpl, containing 0.5mM
ATP, CTP, GTP and a ratio of 35S-UTP (800 Ci/mmol, Amersham International pic,
Amersham, UK) and cold UTP to a specific activity of 3-5x108. lOmM DTT, RNase
inhibitor (Gibco BRL), lx transcription buffer (40mM Tris-HCl, 6mM MgCf, 2mM
spermidine, 10mm NaCl) and 1U SP6 polymerase at 40°C for lh. Transcription was
terminated by application of 1 unit DNasel (RNase free, Gibco BRL) for 10 min at
37°C. Generated probes were then extracted either by;
1) eluting down a NICK column (Pharmacia Biosystems Ltd, Milton Keynes
UK)
2) isolation with phenol:chloroform:isoamyl alcohol, and subsequent
precipitation of the RNA with lp.1 glycogen, 0.5M ammonium acetate and 2.5x vol
ethanol (Hayman Ltd, UK) at -80°C for 10 min. The pellet was recovered by
centrifugation at 14,000 rpm, dried under vacuum and resuspended in DEP water.
The amount of P-emitting radioactivity in 1 pi of the manufactured probe was
counted by scintillation, to give an estimate of the total activity of the probe. To
check for incorporation of nucleotides and degradation of the probe lpl was
electophoresed on a 4% polyacrylamide denaturing gel run in lxTBE buffer and
exposed to P-max film. Successfully made probes were stored at -20°C.
2.3.4 Hybridisation and washing
Cut sections were removed from -80°C storage and postfixed in 4%
paraformaldehyde in 0.1 M phosphate buffered saline (PBS) for 10 min. This was
followed by 3x5 min washes in RNase free 2xSSC containing diethylpyrocarbonate
(0.02%). The synthesised cRNA probes were denatured by heating to 70°C and
added to hybridisation buffer to give lOxlO6 counts/ml. 200pl of this hybridisation
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mix was added to each slide and hybridisation carried out overnight in sealed
containers at 50°C, humidified with box buffer. Slides were subjected to 3x5 min
washes in 2xSSC, before incubation with RNase A (30pg/ml in RNase buffer) for lh
at 37°C. This was followed by a washes in 2xSSC for 10 min, and O.OlxSSC at 55°C
and room temperature for lh each. Sections were dehydrated with graded ethanol
(50%, 70%, 90%) in 0.3M sodium acetate, air dried and dipped in NTB2
autoradiography emulsion (Kodak, UK) diluted 1:1 in distilled water at 42°C.
Sections were exposed for 2-3 weeks at 4°C, counterstained with haemotoxylin and
eosin and coverslipped with DPX mountant. Sections were viewed at 20x
magnification by microscopy, allowing mRNA expression to be visualised as
individual silver grains. Individual silver grains per section were quantified in the
different diameters of sensory neurones, see section 1.2.2, using circles with
diameters of 20pm and 40pm and computer aided image analysis (Seescan,
Cambridge, UK). Background counts, measured from non-expressing regions of the
section using the 20pm and 40pm diameter circles, were averaged and subtracted
from the respective foreground counts, to negate the effects of non-specific probe
binding. Total cells and number of clearly expressing cells within both sizes of
neurones were counted by eye under 20x magnification in order to calculate the
proportion of expressing neurones.
2.3.5 Role of protein synthesis in increases in q-CGRP encoding transcripts
To investigate whether the observed increases in a-CGRP encoding mRNAs were
dependent on the de novo synthesis of a protein, such as a transcription factor,
cycloheximide was injected systemically at a non-lethal dose (3mg/kg in sterile
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saline, i.p. Rothblum et al 1976). 60 min after cycloheximide administration animals
were injected with FCA (as described in 2.1) and killed 30 min thereafter. Positive
controls received FCA and were sacrificed 30 min after injection. The effects of
cycloheximide injection alone were studied in animals receiving cycloheximide, but
no FCA, these animals were killed 90 min after cycloheximide injection. a-CGRP
encoding mRNAs were quantified in DRG neurones with diameters < 20pm as
described above.
2.3.6 Statistics
Experimental in-situ hybridisation data is expressed as percentage of untreated
control values and presented as mean±S.E.M. and compared by ANOVA followed
by Dunnett's post hoc test. The Null hypothesis was rejected at the 5% level.
2.4 Sub-cloning of Intronic Sequence of [3PPT-A
mRNA levels in a tissue are dependent on the rate of production and rate of
breakdown, thus quantification ofmRNA as described above only gives steady-state
levels. The production of new mRNA due to induction of genes can be assessed by
measuring levels of hnRNA. This can be achieved by in-situ hybridisation using a
probe to an intronic sequence of the gene of interest, the subcloning of a probe for an
intronic sequence of pPPT-A is described below.
2.4.1 Solutions
TB (Luria-Bertoni) broth 1% w/v bacto-tryptone, 0.5% w/v yeast
extract (both Difco Laborities,






1 % low melting point agarose gel
autoclave
As LB broth except with 1.5% (w/v)
bacto agar (Difco Laborities) and
autoclave
LB agar was melted in the microwave,
allowed to cool until warm, and if
required ampicllin (lOOmg/ml was
added prior to pouring into sterile
plastic 100mm petri dishes
50mM glucose, 25 mM Tris-HCl (pH
8.0), lOmMEDTA
Prepared by combining 60 ml 5M
potassium acetate, 11.5ml glacial acetic
acid, 28.5ml water. The final solution is
3M with respect to potassium, 5M with
respect to acetate
As for 1% agarose gel, but using low
melting point agarose (Gibco BRL)
2.4.2 Generation of insert
An approximately 700bp fragment within intron E of PPPT-A was produced by
BamHl and Hindlll digestion of a genomic clone of rat PPPT-A (Carter and Krause
1990) in lx restriction buffer (6mM Tris-HCl, 6mM MgCl2, lOOmM NaCl, ImM
DTT) at 37°C for lh. Resulting DNA fragments were separated by size using
electrophoresis on a 1% low melting point agarose gel. The band corresponding to
700bp was cut from the gel and extracted from the gel using a Hybaid recovery DNA
purification kit (Hybaid Ltd, Teddington, UK).
55
2.4.3 Ligation of insert into pGEM3
pGEM3 was cut with BamHl/Hindlll and purified as described 2.4.1. The 700bp
fragment was ligated into pGEM3 using T4 DNA ligase and ImM ATP in lx ligase
buffer (30mM Tris-HCl, lOmM MgC^, lOmM DTT) overnight at 37°C, at ratios of
fragment to vector at 8:1 and 12:1 to optimise conditions.
2.4.4 Preparation of competent bacteria
A single colony of HB101 Escherichia coli was inoculated into 2ml of LB broth and
grown overnight in a shaking incubator at 37°C. Cells were subsequently
resuspended in 40ml LB broth and grown to mid-log phase (Aeoo^ 0.4-0.8) the
resulting cells were then harvested by centrifugation in a Beckman JA20 rotor/J2MC
centrifuge at 6000rpm, 4°C for 5 min. Cells were resuspended in 10ml ice cold 0.1M
CaCh and placed on ice for lOmin to lh. The cells were collected by repeating
centrifugation and resuspended in 2ml 0.1M ice cold CaCE. Cells were stored on ice
until used, a maximum of 4 days later.
2.4.5 Transformations
The method for this stage follows the protocol set out by Sambrook et al, 1989.
lOOpl of competent cells were mixed with 10-100ng of plasmid DNA and placed on
ice for 10 min, prior to heat shock at 42°C for 90 seconds. Transformed cells were
plated out onto LB agar plates containing lOOpg/ml ampicillin with an ethanol
flamed glass spreader. Plates were inverted and incubated overnight at 37°C. Plates
for positive control, pGEM3, and negative control, with no plasmid, were run in
parallel. Viable colonies were those which had been transformed into plasmids
containing an ampicillin resistance gene, P-lactamase.
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2.4.6 Small scale preparation of plasmid DNA
To check for successful insertion, a colony was taken from the plate, suspended in
2ml LB broth containing lOOpg ampicillin and grown overnight at 37°C in a rotator.
Bacterial pellets were centrifuged in eppendorf tubes for 30 s and resuspended in
lOOpl GTE buffer. Cells were lysed with 200pl 1%SDS/0.2M NaOH and neutralised
with 150pl potassium acetate. DNA was isolated by precipitation with
phenokchloroform, and resuspended in TE/RNase. 5pi was cut with Hind III/ Bam
HI as described above and run on 1% agarose gel to verify successful insertion. Cells
from a colony with the inserted fragment were transferred to a plate and grown
overnight at 37°C. The remaining cells were added to 500 ml LB/500pl ampicillin
(lOOmg/ml), and grown overnight at 37°C in a rotator.
2.4.7 Large scale preparation of plasmid DNA
Cells were harvested at 6,000 rpm for 5 min at 4°C using a Beckman J-14 rotor in a
Beckman J2-MC centrifuge. The resulting bacterial pellet was resuspended in 12ml
GTE, mixed well with 24 ml freshly prepared 1%SDS/0.2M NaOH and stored on ice
for 5 min. 16 ml of ice cold potassium acetate was added, mixed, and left on ice for a
further 10 min, prior to centrifugation at 6,000 rpm for 10 minutes at 4°C in the J-14
rotor. The resultant supernatant was strained through gauze into a fresh 250ml
centrifuge pot, 32 ml isopropanol added and left at room temperature for 30 min
whilst the DNA was precipitated. The plasmid DNA was pelleted by centrifugation
at 10,000 rpm for 3min at 4°C. The pellet was air dried and resuspended in 2.2ml TE.
2.7g CsCl was added, and dissolved, and then lOOpl ethidium bromide added. This
mixture was transferred to a 3ml Beckman Quickseal tube and the weight made up to
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5.8-6g by the addition of a saturated solution of CsCl in TE. Centrifugation was
carried out using a TLA100.3 rotor in a Beckman Optima TLX Ultracentrifuge either
at 100,000 rpm for 4h or at 70,000 rpm overnight. Banded plasmid DNA was
removed using a needle and syringe through the tube wall, and transferred to a fresh
ultracentrifuge tube and CsCl in TE was added and recentrifuged as described above.
The resultant band was extracted as before and the ethidium bromide removed using
isopropanol, until the isopropanol was no longer pink. CsCl was removed from the
extracted plasmid preparation was dialysed against two 1 litre changes of TE at 4°C.
Concentration of the recovered plasmid DNA was evaluated by measuring
absorbency at A260 in a Shimadzu UV-160A spectrophotometer, the absorbance of
50pg/ml DNA being 1.0 at A260- Plasmid DNA was stored at -20°C.
"2 C
In situ hybridisation using S-labelled cRNA probes generated from the plasmid
containing sequence from intron E of PPPT-A, termed pDBl, was carried out in
DRG neurones with diameter< 20pm as described in 2.3. 30 min after FCA injection.
Data was analysed by ANOVA followed by Dunnett's post hoc test, the Null
hypothesis was rejected at the 5% level.
2.5 Protein Levels of SP and CGRP after FCA Administration
2.5.1 Peptide extraction
Joint inflammation was induced as previously described and innervating L5 DRG
dissected from rats 30 min, 1,2,4 and 8h after adjuvant injection and stored at -70°C.
Peptides were extracted from L5 DRG by acid hydrolysis with 2M acetic acid, and
samples evaporated to dryness by centrifugation under vacuum in a Savant DNA 110
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Speed Vac, and resuspended in 500pl radioimmunoassay buffer (0.1M sodium
phosphate, 0.05M sodium chloride, 0.1% bovine serum albumin, 0.01% sodium
azide, pH 7.4) and stored at -70°C.
2.5.2 Radioimmunoassv
RIA was carried out using kits for SP and CGRP (Peninsula Laboraties, USA) as
follows: lOOpl of peptide standards (0.1-128pg) or sample were incubated with
lOOpl rabbit primary antibody at 4°C for 16-24h. 15,000 cpm of I2:I-peptide in lOOpl
was added and incubated at 4°C for a further 16-24h. Bound and free radiolabel was
separated by precipitation with lOOpl goat anti-rabbit immunoglobulin and rabbit
serum. Supernatants were removed by aspiration and samples counted in a beta-
counter. The following internal controls were carried out; total counts, 200pl RIA
pr
buffer and 15,000 cpm of I-peptide but was not aspirated; non-specific binding,
200pl RIA buffer and 15,000 cpm of 125I-peptide; total binding, lOOpl RIA buffer,
19 S
lOOpl rabbit primary antibody, and 15,000 cpm of T-peptide.
Experimental data is expressed as percentage of untreated control values and
presented as meaniS.E.M. Data was analysed by ANOVA followed by Dunnett's
post hoc test. The Null hypothesis was rejected at the 5% level.
2.6 The Role of Sensory Neural Activity in FCA Induced Joint Inflammation
2.6.1 Neural recordings from small diameter sensory nerves
The early effects of 0.1 ml FCA intra-articular injection into the knee joint, which
shares a common innervation with the tibio-tarsal joint, were studied. Rats were
59
anaesthetised with urethane (ethyl carbamate 25% w/v, 6 ml/kg body weight i.p.).
Neural discharge from afferent fibres innervating the knee joint was measured by
exposing the medial articular nerve where it branched from the saphenous nerve and
dissecting it from muscle and connective tissue, rupturing cutaneous branches of the
medial articular nerve, thereby restricting neural recordings to fibres innervating the
joint capsule and surrounding tissue. The exposed nerve was covered in liquid
paraffin, cut centrally to abolish efferent nerve activity and recordings were taken
from fine nerve filaments containing 1-3 active units using bipolar platinum-iridium
(90:10) electrodes. The electrical signal was amplified (Neurolog NL103 and 105
amplifiers) and displayed on a storage oscilloscope (Tektronix 5113). The signal was
digitised using a digital audio processor (Sony PCM 701-ES) for storage on
videotape (videotape recorder: Sony Betamax SL-HF100UB). The output from the
amplifier was passed through a filter (NL115 lOHz-lKHz) and a voltage
discriminator (Digitimer D130). Action potentials from that fell within the selected
window, defined as the response of a polymodal C fibre to capsaicin (3pg i.a.) and/or
mechanical probing of the joint capsule, generated an output pulse that was counted
by a PC using software developed in-house. Experiments were conducted by D.
Kelly.
2.6.2 Requirement of neural activity for the increases in (3PPT-A and q-CGRP
encoding mRNAs
To investigate whether the increase in neural activity following FCA injection
underlied the increases in PPPT-A and a-CGRP encoding mRNA, levels of these
transcripts were measured in L5 DRG ipsilateral to FCA injection in rats pre-
administered with local anaesthetic. 2% lignocaine was injected around the sciatic
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nerve, in the mid-thigh region. Animals which showed a paralysis of the limb 30
minutes after injection were subsequently injected with FCA as described in section
2.1 and in-situ hybridisation carried out as described in section 2.3.
2.7 Progression of Inflammatory Indices
Oedema formation was monitored by measurement of tibio-tarsal joint circumference
immediately before (t=0) and 30 min, 1, 2 4 and 8h after injection of FCA (as
described in section 2.1). The development of mechanical hyperalgesia was assessed
at the same time points, by pressure applied to the tibio-tarsal joint required to induce
reflex withdrawal of the limb. Measurements were made using a Grass Force-
Displacement Transducer connected via a Bridge amplifier and Mac Lab 4S (both
ADI instruments) to a Power Mac G3 running Chart software. 3 measures per time
point were taken and averaged. Data was analysed by ANOVA followed by Dunnetts
Post hoc test (p>0.05), the Null hypothesis was rejected at the 5% level.
2.8 Histology of Tibio-tarsal Joints at Time Points After FCA Induced Joint
Inflammation
Untreated animals and animals 1, 8 and 24h after FCA injection were anaesthetised
with sodium pentobarbitone (60mg/kg i.p.) and perfused via the left ventricle with
heparinised saline (500 U/kg, 10ml), followed by 10% formol saline (50-100 ml),
fixing the hind limbs. Flind limbs were removed and stored in 10% formol saline.
Tibio-tarsal joints were fixed in 40% buffered formalin and processed into paraffin




Oligonucleotides were designed following sequence analysis of P-PPT A and a-
CGRP and application of the guidelines for design set out in section 5.1. Sequences
were cross-referenced with pre-existing sequences using computer software available
at the UK MRC Human Genome Mapping Project Resource Centre (HGMP).
Oligonucleotides were synthesised with a backbone of phosphorothioate bases, each
oligonucleotide was 17 bases long (Oswel, Southampton, UK). The oligonucleotides
used are shown in table 2.1:
PPT ATG 5' ATT TTC ATG TTG GAT TT 3'
PPT Exon 2 5' CAA TAA TTT AGA TCA TC 3'
CGRP ATG 5' TTC AGA AAG CCC ATG AT 3'
Scramble 5' GTT ATC TTT GTA TGT AT 3'
Table 2.1 Sequences of antisense oligonucleotides applied to cultures of DRG
neurones
Cultures of adult rat dorsal root ganglia
Rats, two per experiment, were killed by chloroform, and the spinal cord removed
under sterile ethanol conditions. The spinal cord was split exposing the DRG (40-
45), which were removed under microscope and placed in HAMS F-14 serum free
media, containing 4% Ultroser G (Gibco BRL), 1% penicillin/streptomycin (Gibco
BRL), 0.5% L-glutamine. The ventral root was separated from ganglionic body,
which was transferred to a tissue culture dish, the medium removed and replaced by
1.8ml HAMS F-14 and 200pl 10X collagenase. After 3 hours the DRG were
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removed and washed with serum free HAMS F-14 medium, spun in a centrifuge and
resuspened in 1.8ml serum free HAMS F14 and 200pl trypsin at 37°C for 30
minutes. Trypsin action was stopped by addition of HAMS F14 medium containing
serum, cells resuspended in 3ml of HAMS F14 and pulped by trituration into a
suspension. Cells were left overnight to attach to a plate previously coated with
polyornithine (500pg/ml). The media, containing non adherent cells and dead cells,
myelin and axonal debris and non neuronal matter, was removed. Neurons only
lightly attach to plates, so can be removed by gentle pipetting of serum containing
media, leaving firmly attached non-neuronal cells on the plate. Neuronal cells were
plated to 10,000 cells per well coated with polyornithine (500p,g/ml) and laminin
(5p.g). 75p.l of HAMS F-14 medium as described above and mouse salivary gland
derived NGF (50ng/ml) was added to each well. Neuronal cell cultures were
maintained at 36.5°C, with 97% air:3% CO2 and in the presence of cytosine
arabinose (10pM), to prevent cell division and the proliferation of non-neuronal
cells, and grown overnight.
Each antisense oligonucleotide (AS-ON), at concentrations of 2.5pM and 500nm in
serum free medium, was applied to DRG cultures and incubated for 18h at 37°C. The
efficacy of each AS-ON treatment was assessed by levels of SP and CGRP extracted
from each culture by hydrolysis with 2M acetic acid, and stored at -20°C until
quantified by radioimmunoassay.
Radioimmunoassay
Samples were evaporated to dryness in a vacuum oven (45°C, 700mmHg) and
resuspended in assay buffer (0.1M PO4, pH 7.6, lg/1 bovine serum albumin). For SP
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assay, standards (0-500 pg/ml) and samples were prepared in a volume of 200pl in
duplicate, and incubated at 4°C for 16 h with 200pi rabbit anti-SP antiserum
(1:80,000 dilution) and 5000cpm in lOOpl of 125I labelled SP. CGRP
radioimmunassay was performed with standards ranging from 0-5000 pg/ml of
human CGRP (Peninsula Laborities, USA). Standards and samples were incubated
for 16h at 4°C with lOOpl of 1:2000 dilution of rabbit anti-human CGRP antiserum
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(Amersham Life Sciences) and 5000cpm 2-[ I] iodohistidyl CGRP (human,
Amersham Life Sciences). Bound radiolabel was separated from free label by
precipitation with donkey anti-rabbit gamma globulin antiserum (Scottish Antibody
Production Unit (SAPU), Carluke, UK).
Experimental data was analysed by ANOVA followed by Dunnett's post hoc test, the
Null hypothesis was rejected at the 5% level.
2.10 Western Blots
Solutions
lx Tris-Glycine Electrophoresis Buffer
lx Tris-Glycine Electroblotting Buffer
10% Resolving Gel
Stacking Gel
2.5mM Tris-HCl, 19.2mM glycine,
0.1% w/vSDS
2.5mM Tris-HCl, 19.2mM glycine, 2%
methanol
5 ml 40% acrylamide, 3.0ml 1.875M
TrisHCl (pH8.8), 150pl 10% sodium
dodecyl sulphate. Make up to 15ml with
distilled water. Polymerise acrylamide
with 50f_il 10% ammonium persulphate
(Sigma) and 7.5pl TEMED
0.8ml 40% acrylamide, 0.5ml 1.25M
TrisHCl (pH6.8), 50pl, 10% sodium
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Gel Loading Buffer
dodecyl sulphate. Make up to 5ml with
distilled water. Polymerise with 17pl
10% ammonium persulphate and 5pl
TEMED
5.8ml glycerol, 2.5ml 1.25M TrisHCl
(pH6.8), 2.5ml 2-mercaptoethanol, lg
SDS, 5mg bromophenol blue, and 35ml
distilled water
Sample Preparation
L5 DRG were removed from untreated animals as controls. Single DRG were
homogenised in 60pl loading buffer, boiled for 5 minutes and spun at 13,000 rpm for
10 min. Samples (20pl) were run alongside recombinant p65 and IkB-oc proteins and
pre-stained molecular weight markers between 200,000 and 7,100 kDa on a 10%
resolving acrlyamide gel, over laid by stacking gel solution Gels were run at lOOv,
20 mA in lx Tris-glycine electrophoresis buffer. Proteins were transferred by
electrophoresis to an Hybond ECL nitro-cellulose membrane (Amersham Life
Sciences) activated by immersion in methanol, in lx Tris-glycine electrophoresis
buffer. The membrane was blocked for 1 hour with a 3% powdered milk (Marvel,
Premier Beverages, Stafford, UK), 0.1% Tween (polyoxyethylenesorbitan
monolaurate) in phosphate buffered saline (PBS) and then probed for lh with a
monoclonal mouse antibody raised against IxB-a, diluted 1:1000 in. Unbound
primary antibody was removed with lxl5min and 2x5 min washes with
O.lxTween/PBS. Specific binding was visualised by probing for lh with a secondary
horseradish peroxidase tagged anti-mouse antibody (Scottish Antibody Production
Unit, Carluke, UK), diluted 1.5:10000 in 0.1%Tween/PBS, and application of
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reagents from an ECL detection kit (Amersham Life Sciences). The recombinant
proteins and monoclonal IkB-oc antibody were kind gifts from Prof. D Hay
(University of St Andrews, UK)
2.11 Identification of STAT Transcripts in DRG by Reverse Transcription-
Polvmerase Chain Reaction (RT-PCR)
Extraction ofRNA
RNA was extracted from DRG using the guanidium thiocynate method as previously
described by (Chomczynski and Sacchi 1987). One DRG was homogenised in 500pl
denaturing solution (4M Guanidium thiocyanate, 0.025M sodium citrate, 0.5%
sarcosyl, 0.1M p-mercaptoethanol), 50pl 2M sodium acetate added and vortexed.
After the addition of 500pl water saturated phenol, and lOOpl chloroforrmisoamyl
(24:1), samples were cooled on ice for 15 min and centrifuged for 20 min at 14,000
rpm. The upper aqueous phase was removed and the RNA in solution precipitated by
the addition of 200pl isopropanol and storage at -20°C for at least lh. The
precipitated RNA was collected as a pellet by centrifugation for 20 min, and the
supernatant removed. The pellet was washed with 75% EtOH, dried and resuspended
in 50pl DEP water. The concentration of RNA was deduced by absorbance
spectrometry at 260 and 280nm in a Genequant RNA\DNA Calculator (Pharmacia




Using the Promega reverse transcription system cDNAs were produced by adding
lpg of RNA to the following reaction mixture to a total volume of lOpl: 5mM
magnesium chloride, lOmM Tris-HCl (pH 8.8), 50mM KC1, 0.1% triton, ImM
dNTPs, 1 unit/jixl RNase inhibitor, 15 unit/pg AMV reverse transcriptase, 0.05pg/pl
oligo (dT)i5 primer. The mixture was incubated at 42°C for 45 min.
Polymerase chain reaction (PCR)
cDNAs produced by reverse transcription were amplified by polymerase chain
reaction in a Hybaid Omnigene PCR machine using 1U Taq DNA polymerase
(Boehringer Mannheim UK (Diagnostics/Biochemicals) Ltd Lewes, UK), 400nm
degenerate primers designed to amplify the conserved SH-2 domain of STAT 1,3 and
4 (5' AGC TCT AGA t/cTN CCT GTc/g GTG g/aTG ATc/t TC 3' and 5' TGA
CTC GAG CTG AAT CTt/a Aa/gC Ag/ag/a AAt/c GTC CC 3' a kind gift from C.
Watson) 200pm dNTPs, 1.5mM MgCh, 50mM KC1, 20mM Tris-HCl (pH 8.4) to a
final volume of 50pl in ultrapure water. PCR cycles were performed as follows,
5min at 95°C; 30 cycles of 30°C at 95°C, 1:30 at 60°C, 2min at 72°C; 1 cycle of 8
min at 72°C.
As a positive control PCR using primers for the ubiquitously expressed, structural
protein p-actin (5' ATGGATGACGATATCGCTC 3' and 5'
ATGAGGTAGTCTGTCAGGT 3') was carried out as detailed above under the
following cycles: 5 min at 95°C; 35 cycles of 45 s at 96°C, 1:30 min at 60°C, 2 min at
72°C;
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Cloning of PCR products
A specific band, found in both DRG and liver extracts was excised from a 1% low
melting point agarose gel containing ethidium bromide, under UV illumination and
DNA extracted using a Hybaid recovery DNA purification kit (Hybaid Ltd). Excised
bands were ligated into pGEMT-Easy (Promega Ltd) using T4 DNA ligase and ImM
ATP in lx ligase buffer (30mM Tris-HCl, lOmM MgCl2, 10mM DTT) at 4°C
overnight and transformed into JM109 High Efficiency Competent Cells (Promega
Ltd ) by heat shock as follows; the cells were transferred from 20 min on ice to a
water bath at 42°C for 45 seconds and then back to ice for 2 min. SOC medium (2g
Bacto-tryptone, 0.5g bacto yeast extract, 1ml 1M NaCl, 0.25ml 1M KC1, 1ml 2M
Mg2+, 1ml 2M glucose, to 100ml with distilled water), was added to the cells and
incubated for 1.5h at 37°C in a rotator within an incubator. Cells were then plated on
LB plates and grown overnight at 37°C. DNA was extracted from a single colony as
described in section 2.4.5. and cut with EcoRl, for lh at 37°C, to check for inserts.
Sequencing of cloned PCR products
DNA extracted from a colony which contained an insert was sequenced using a
Thermo Sequenase radiolabeled terminator cycle sequencing kit (Amersham). Four
reactions were set up, each containing 0.5pl of a different 33P labelled
diodeoxyribonucleotide (ddNTP) and 2pl of a mix of the four deoxyribonucleotides
(dNTP). To each of these four tubes 4.5pl of a mixture (2pl reaction buffer, 1.5pg
DNA, 2pmol 5' primer, 2pl Thermo Sequenase polymerase (4U/pl) water to 20pl)
was added, and placed in a Hybaid Omn-E thermal cycler and subjected to the
following program, 95°C for 30 seconds, 55°C 30s, 72°C for 90s and repeated for 40
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cycles (sequencing performed by Val Lyons). The addition of 4pl of stop solution to
each tube terminated the reaction, and samples stored at -20°C. Samples were run on
a 6% acrylamide/urea gel, which was made as follows; 5.7g acrylamide, 0.3g bis-
acrylamide, 45g urea, 5ml 20x glycerol tolerant gel buffer (216g Tris base, 72g
taurine, 4g l^EDTA.LLO, H2O to 1 litre) per 100ml. Acylamide was polymerised by
10% ammonium persulphate and TEMED. Gels were run for 4.5h at 1.8kV and
exposed to fdm (X-OMAT AR, Kodak, UK) for 48 h.
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3 Plastic changes in synthesis of neuropeptides in sensory
nerves following peripheral inflammation
3.1 Introduction
As detailed in chapter 1.6, SP, NKA and CGRP have been implicated in both central
and peripheral events following inflammation. The control of sensory neuropeptide
biosynthesis in the cell bodies of sensory neurones is of considerable interest and
relevance in the aetiology of the inflammatory process. Previous experiments in the
laboratory have shown that within 8h of FCA injection SP and CGRP encoding
mRNAs are increased in L5 DRG in cell bodies of small diameter nerve fibres
innervating the injected joint. In contrast, mRNAs encoding vasoactive-intestinal
peptide (VIP) or somatostatin (SOM), are unaffected by FCA injection (Donaldson et
al 1992). The molecular mechanisms underlying these changes are unknown,
however within lh of FCA injection mRNA encoding the transcription factor AP-2
was increased, then decreased to control levels at subsequent time points (Donaldson
et al 1995 b). mRNAs encoding members of the AP-1 family, NGFIA or NGFIB
were not detected or showed no changes in expression within 8h of FCA injection.
Intriguingly, EMSA analysis has revealed an active AP-2 site in the promoter region
of the rat PPT-A gene between bases -865 and -47 (Quinn et al 1995), suggesting
that AP-2 could regulate PPT-A expression.
There is a growing body of evidence that there are also plastic changes within large
diameter fibres, responsible for relaying low threshold, innocuous stimuli such as
touch and pressure, in models of inflammation. For example the number ofAp fibres
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expressing SP increases 48h after inflammation induced by injection of turpentine oil
into the hind paw (Neumann et al 1996).
An exploration of the timecourse of neuropeptide expression following FCA
injection may give an indication of the molecular mechanisms underlying plasticity
in gene expression. mRNA in-situ hybridisation (ISH) offers a technique for
quantifying (3PPT-A and a-CGRP mRNAs in the different populations of neurones
found in DRG (described in 1.2.2). Furthermore the use of probes complementary to
intronic sequences can be employed to quantify hnRNA levels and hence de novo
gene expression. A probe complementary to a sequence from intron E of PPPT-A
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Figure 3.1 Construction ofpDBl, an approximately 700bp sequence from intron E of
or
PPPT-A, which was subsequently inserted into pGEM3, from which S labelled




3.2.1 BPPT-A and a-CGRP mRNA expression of in small diameter DRG neurones
Photomicrographs of PPT mRNA expression are displayed in figures 3.2 and 3.3. In-
situ hybridisation studies showed that within 30 min of adjuvant injection there are
marked rises in expression of both (3PPT-A (figure 3.4) and a-CGRP (figure 3.5)
encoding mRNAs per small diameter neurone (diameter <20pm) in innervating
DRG. After 60 min, neuronal expression of both transcripts had approximately
doubled compared to either untreated controls or contralateral DRG, which showed
no changes throughout the first 8h of inflammation. Significantly elevated PPPT-A
and a-CGRP encoding mRNA levels per expressing neurone were maintained up to
8 h after adjuvant injection. Saline injection did not increase PPPT-A or a-CGRP
mRNA expression in DRG neurones, in fact a-CGRP levels were significantly
decreased (figures 3.6 and 3.7).
Over the same time course the proportion of small neurones with clear expression of
a-CGRP and PPPT-A mRNAs was also monitored. 30 min after injection no change
was seen, however by 1 hour the proportion of expressing neurones had increased
significantly ipsilateral to injection. This increased proportion of a-CGRP and pPPT-
A expressing neurones was maintained at subsequent time points (figures 3.8 and
3.9).
To determine whether the increase in PPT mRNA is reflected by new transcription,
ISH was performed using a probe complementary to intron E of the P-PPT gene.
Photomicrographs of this experiment are displayed in figure 3.10 and 3.11.
Quantification of silver grains demonstrated that within 30 min of injection of FCA
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there was increased hybridisation in small diameter neurones (figures 3.12),
correlating with the increases seen in mature mRNA. This suggests that the early
increases in mRNA expression are, at least in part, due to increased transcription.
Cycloheximide pre-treatment did not affect the FCA-induced increase in oc-CGRP
mRNA per small diameter neurone 30 min after injection (figure 3.13), indicating
that de novo protein synthesis is not a prerequisite for the increase in a-CGRP gene
expression. Cycloheximide treatment alone did not cause any changes in a-CGRP
encoding mRNA levels over the 90 min experiment.
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Figure 3.2 Dark field photomicrograph of PPT mRNA expression in L5 DRG
neurones of untreated (control) rats. Original magnification 40x.
Figure 3.3 Dark field photomicrograph of PPT mRNA expression in rat L5 DRG
neurones lh after ipsilateral to injection ofFCA around the tibio-tarsal joint. Original
magnification 40x. Note the increased density of silver grains per neurone and
increased number of expressing neurones compared to figure 3.2.
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Time after intradermal injection of FCA (h)
Figure 3.4 Expression of mRNA encoding P-PPTA in small diameter (<20pm) L5
DRG neurones ipsilateral to intradermal injection of FCA (150pg) around the tibio-
tarsal joint. Values (mean±SEM) expressed as % untreated control. Null hypothesis

























Time after intradermal injection ofFCA
Figure 3.5 Expression of mRNA encoding a-CGRP in small diameter (<20|_im) L5
DRG neurones ipsilateral to intradermal injection of FCA (150pg) around the tibio-
tarsal joint. Values (mean+SEM) expressed as % untreated control. Null hypothesis
rejected at p<0.05, n=5.
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Figure 3.6 Levels of PPPT-A mRNA in innervating L5 DRG 30 min after the
injection of saline or FCA around the ipsilateral tibio-tarsal joint. Values




Figure 3.7 Levels of a-CGRP encoding mRNA in innervating L5 DRG 30 min after
the injection of saline or FCA around the ipsilateral tibio-tarsal joint. Values
(mean±SEM) are expressed as % of untreated controls, n=3-5. *p<0.05 compared
with untreated controls.
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Time after intradermal FCA injection (h)
Figure 3.8 Proportion of small diameter (<20pm) L5 DRG neurones expressing
mRNA encoding P-PPTA within 8h of ipsilateral intradermal injection of FCA
(150pg) around the tibio-tarsal joint. Values (mean±SEM) expressed as % untreated
control, n=5. *p<0.05 compared with untreated controls.
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Time after intradermal injection ofFCA (h)
Figure 3.9 Proportion of small diameter (<20pm) L5 DRG neurones expressing
mRNA encoding a-CGRP within 8h of ipsilateral intradermal injection of FCA
(150pg) around the tibio-tarsal joint. Values (mean±SEM) expressed as % untreated
control, n=4-5. *p<0.05 compared with untreated control.
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Figure 3.10 Dark field photomicrograph of expression of hnRNA complementary to
intron E of pPPT-A in rat L5 DRG neurones of untreated (control) rats. Original
magnification 40x.
Figure 3.11 Dark field photomicrograph of expression of hnRNA complementary to
intron E of pPPT-A in rat L5 DRG neurones 30 min after ipsilateral injection ofFCA
around the tibio-tarsal joint. Original magnification 40x. Note increase density of





















Figure 3.12 Expression of hnRNA encoding intron E of P-PPTA in L5 DRG 30 min
after ipsilateral intradermal injection of FCA around the tibio-tarsal joint. Values
(mean+SEM) expressed as % untreated control. n=3-4. *p<0.05 compared with
untreated controls.
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control FCA FCA+CHX CHX
Figure 3.13 Effect of pre-treatment with cycloheximide (3mg/kg ip) on the
expression of a-CGRP encoding mRNA in L5 DRG 30 min after ipsilateral
intradermal injection of FCA (150pg) around the tibio-tarsal joint. Values
(mean±SEM) expressed as % of untreated control, n=3-4. *p<0.05 compared with
untreated control.
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3.2.2 BPPT-A and g-CGRP mRNA expression in large diameter DRG neurones
The expression of pPPT-A (figure 3.14) and a-CGRP (figure 3.15) encoding
mRNAs per large diameter neurone (diameter >40pm) after FCA injection initially
mirrors that in the small neurones, with a significant increase within 30 min of
adjuvant injection, peaking at lh (180% and 166% of control values for P-PPTA and
a-CGRP encoding mRNAs respectively). At subsequent time points levels decrease,
so that by 4h levels of both transcripts are similar to untreated controls. Over the
same time course there were no observed increases in the proportion of large
diameter cells expressing P PPT-A or a-CGRP encoding mRNAs, indicating that
there is no recruitment of previously non-expressing neurones (figures 3.16 and
3.17). Indeed, there is a significant decrease in the proportion of large diameter
neurones expressing a-CGRP encoding mRNAs 8h after adjuvant injection (figure
3.17).
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Time after intradermal injection of FCA (h)
Figure 3.14 Expression of mRNA encoding (3-PPTA in large diameter (>40pm) L5
DRG neurones ipsilateral to intradermal injection of FCA (150pg) around the tibio-
tarsal joint. Values (mean±SEM) expressed as % untreated control, n=3-5. *p<0.05
compared with untreated control.
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Figure 3.15 Expression ofmRNA encoding a-CGRP in large diameter (>40pm) L5
DRG neurones ipsilateral to intradermal injection of FCA (150pg) around the tibio-
tarsal joint. Values (mean±SEM) expressed as % untreated control, n=3-5. *p<0.05
compared with untreated control.
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Time after intradermal injection ofFCA (h)
Figure 3.16 Proportion of large diameter (>40pm) L5 DRG neurones expressing
PPPT-A mRNA ipsilateral to intradermal injection of FCA (150pg) around the tibio-
tarsal joint. Values (mean+SEM) expressed as % untreated control, n=4-5.
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Time after intradermal injection of FCA (h)
Figure 3.17 Proportion of large diameter (>40pm) L5 DRG neurones expressing
mRNA encoding a-CGRP within 8h of ipsilateral intradermal injection of FCA
(150pg) around the tibio-tarsal joint. Values (mean±SEM) expressed as % untreated
control, n=3-5.
3.23 Levels of substance P and CGRP in DRG
To explore whether changes in mRNA are reflected in changes in levels of encoded
peptide, radioimmunoassay was employed to monitor SP and CGRP levels in
innervating DRG following injection of FCA. In line with increases in their encoding
mRNAs, levels of both substance P and CGRP immunoreactivity also increased in
ipsilateral DRG within 30 min of adjuvant injection (figures 3.18 and 3.19) peaking
at 60 min. At subsequent time points, peptide levels decreased and reached control
values 4 hours after injection. Indeed, substance P content of DRG from injected
animals was significantly lower than in noninjected control animals 8 hours after
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adjuvant injection.
Figure 3.18 Levels of substance P in L5 DRG within 8h of ipsilateral intradermal
injection of FCA around the tibio-tarsal joint. Values (mean±SEM) expressed as %
untreated control. n=3-5, *p< 0.05, compared with untreated control.
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Time after intradermal injection of FCA (h)
Figure 3.19 Levels of CGRP in L5 DRG within 8h of ipsilateral intradermal injection
of FCA around the tibio-tarsal joint. Values (mean±SEM) expressed as % untreated
control, n=3-5. *p<0.05 compared with untreated control.
3.3 Discussion
Data presented here demonstrate a rapid response to FCA injection; 30 min after the
injection of adjuvant there is an increase in pPPT-A and a-CGRP encoding mRNAs
in both small and large diameter neurones, without an apparent change in the
population of expressing cells. These increases are not apparent in L5 DRG of
animals injected with saline. By lh there is an increase in the proportion of small
diameter neurones expressing both transcripts, which is maintained up to 8h post
FCA injection. No change occurs in the proportion of large diameter neurones
91
expressing pPPT-A and a-CGRP encoding mRNAs in the first 8h after FCA
injection. The increase in a-CGRP encoding mRNAs in L5 small diameter neurones
ipsilateral to FCA injection is not prevented by the prior-administration of the protein
synthesis inhibitor cycloheximide.
It is possible that the upregulation of neuropeptide gene expression occurs in small
and large neurones via a common signalling mechanism. The speed of the increases
in neuropeptide mRNAs suggests that they are independent of AP-2, which does not
show increases in its encoding mRNA until lh after FCA injection (Donaldson et al
1995 b). This hypothesis is supported by the observation that cycloheximide pre-
treatment does not prevent the increase of a-CGRP encoding transcripts in small
diameter neurones 30 min after FCA injection, implying that de novo synthesis of
AP-2 or any other transcription factor is not necessary in the initial increase in
neuropeptide gene expression in response to FCA induced inflammation The
increase in sensory neuropeptide mRNAs is augmented by a recruitment of a
population of previously non-expressing small diameter cells within the first hour of
inflammation. This may reflect the effects of strong transcriptional stimulation in
neurones expressing low levels of PPPT-A or a-CGRP encoding transcripts, which
were previously below the detection limit of probes used in this in-situ hybridisation.
Alternatively, it may signify a change in neuronal phenotype of a population of small
diameter cells. In small diameter cells both pPPT-A and a-CGRP have a high basal
expression, thus an increase in mRNA expression per neurone coupled with the
recruitment of a subpopulation of previously non-expressing cells within lh of
injection signifies a major response to adjuvant injection with a large increase in
mRNA available for translation. The high levels of PPPT-A and a-CGRP mRNAs
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are significantly elevated in small diameter neurones 8h after injection of FCA, in
agreement with previous data using the same model (Donaldson et al 1992).
The mechanism underlying the decrease in the proportion of large diameter neurones
expressing a-CGRP mRNA at the 8h time point is unknown. It may represent
changes in neuronal phenotype, downregulation caused by an inhibitory feedback
mechanism, or neuronal cell death.
The observation that injection of saline around the tibio-tarsal joint does not cause an
increase in either pPPT-A or a-CGRP encoding mRNAs implies that the
upregulation of these two genes is not due to injection, but attributable to the action
of FCA, most probably its immunogenic properties. The mechanism behind the
decrease in a-CGRP encoding mRNA after saline injection is unknown, though
conceivably may be due to damage to the peripheral nerve caused by the action of
injection, a condition which causes downregulation of CGRP expression in
innervating DRG (Nahin et al 1994).
It is unclear whether the increased amounts of a-CGRP and pPPT-A mRNAs per
small diameter neurone reflect increased gene transcription, or a decrease in the rate
ofmRNA breakdown by nucleases. This question is partially answered by the results
of in-situ hybridisation using a probe complementary to an intronic sequence of PPT-
A. The increases in hnRNA transcripts per small diameter neurones 30 min after
adjuvant injection can be ascribed directly to increased gene expression. This
suggests that the increased hybridisation to the full length PPPT-A probe in small
diameter neurones at the same time point are at least in part due to increased
transcription of the pPPT-A gene. However this does not eliminate a decrease in
mRNA breakdown, and it is conceivable that the increase in total mRNA is due to
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both processes.
In other models of joint inflammation increases in the expression of sensory
neuropeptides have been noted within 8h of inflammatory stimuli. Bilateral hind
limb inflammation induced by intraplantar carrageenan injection caused rapid
increases in PPT and CGRP mRNA levels, within lh of injection, peaking at 2h
(Iadarola and Draisci 1988). This was measured by Northern analysis and so
represents total mRNA from DRG, and gives no information as to the class of nerve
fibre in which these plastic changes occur. A similar argument can be made about
experimental data from rats in which RNase protection assays were used to measure
neuropeptide gene expression in innervating lumbar DRG after hindpaw formalin
injection, which causes an increase in PPT-A mRNA 6h after injection (McCarson
and Krause 1995). Using in-situ hybridisation various investigators have reported
increases in cell numbers expressing PPT-A encoding mRNA. Noguchi and co¬
workers described an increase in number of L5 DRG cells expressing PPT-A within
3h and up to 24h after formalin induced inflammation, of the hindpaw, although they
observed no changes at 30 min or lh (Noguchi et al 1988), this may reflect a
difference between formalin and FCA induced inflammation. FCA intraplantar
injection has previously been reported to cause an increase in the number of
ipsilateral DRG neurones expressing PPT-A mRNA within 6h of induction of
inflammation (Leslie et al 1995), but neither this or the Noguchi publication detail in
which sub-populations of DRG neurones these changes occur. The number of DRG
cells expressing PPT mRNA was also increased within 2 days, and persisted up to 20
days after FCA induced inflammation in the rat tibio-tarsal joint (Fleppleman et al
1993). A similar stimulus increases the number of CGRP immunoreactive DRG cells
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at 2 and 20 days (Hanesch et al 1993).
The increases in pPPT-A and a-CGRP mRNAs are rapidly followed by a swift
increase in the encoded peptides, SP and CGRP, within 30 min of FCA injection,
levels peaking at lh. Peptide levels are not elevated above control levels at any time
point after lh despite the elevated levels of their encoding mRNAs. Indeed by 8h SP
has decreased to a level significantly below control levels. This is likely to be due to
rapid transport of peptides away from the DRG. In inflammation caused by hind-paw
injection of heat killed M. butryricum there is an increase in immunoreactive CGRP
levels in DRG, this increase is augmented by injection of the axonal transport
inhibitor colchicine (Kuraishi et al 1989). This suggests that newly synthesised
CGRP is transported away from the DRG, presumably to the nerve terminals. In
addition axonal transport of CGRP and SP is increased in nerves innervating tissue
inflamed by FCA injection (Donnerer et al 1992). Supporting the view that decreases
in DRG peptide levels from the peak lh after adjuvant injection may be attributable
to increased axonal peptide transport at a rate which exceeds that of peptide
synthesis. One of the enzymes responsible for neuropeptide degradation, neutral
endopeptidase (NEP, also called enkephalinase, EC 3.4.24.11), cleaves CGRP at a
rate much slower than SP (Katayama et al 1991). This may account for the
discrepancy between SP and CGRP levels 8h after FCA injection, where CGRP
levels are similar to those found in DRG of untreated animals, but SP are
significantly lower than controls.
At time points lh after FCA injection there is an increase in the number of small
diameter neurones expressing PPPT-A and a-CGRP mRNAs. Radioimmunoassays
described here were carried out on whole DRG, but it seems likely that this reflects
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an increase in the number of small diameter neurones immunopositive for SP or
CGRP, mirroring the increase in mRNAs. An increase in the number of small
diameter neurones immunopositive for SP or CGRP would effectively increase the
number of fibres capable of mediating noxious and painful stimuli. The net effect
would be maintenance of increased dorsal horn excitability and augmentation of
inflammatory events in the periphery.
There are remarkably similar effects on the expression of pPPT-A and a-CGRP
mRNAs and their encoded peptides. Given that there is strong evidence that SP and
CGRP are co-localised in a number of sites, including small diameter DRG neurones
(Ju et al 1987) it is conceivable that the transcription of both genes are under a
common mechanistic control. Co-ordinated expression of the 2 genes would be
advantageous given the synergistic action of SP and CGRP both peripherally and
centrally (see section 1.6)
As described in chapter 1.2.2, sensory neurones have been classified according to
their conduction velocity and the diameter of their cell bodies. In these experiments
mRNA expression has been quantified in DRG neurones with diameters <20pm and
>40pm. However there is a degree of overlap in the diameter of the different classes
of sensory nerves, for example neurones with a diameter <20pm are likely to be
either C or A5 fibres. Although both C and A8 fibres have been implicated in the
transmission of pain, however these classes of sensory nerves have different
conduction velocities and innervate different laminae of the dorsal horn of the spinal
cord. It is likely that the different classes of nerve fulfil different roles in responses to
inflammatory stimuli. In experiments described here it is not clear in which classes
of nerve fibres the changes in neuropeptide gene expression occur. The B fragment
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of cholera toxin, which binds to GM1 ganglioside, a glycolipid found only in
myelinated A type fibres, conjugated to horseradish peroxidase (Robertson et al
1991). GM1 ganglioside conjugated to horseradish peroxidase has been injected
sciatic nerve to label myelinated nerves in the innervating DRG (Neumann at al
1996), this approach could be used together with neurone diameter and ISH to
elucidate the class of small diameter neurones in which PPPT-A and a-CGRP
mRNA levels increase after FCA injection.
As discussed in chapter 1.13 it has been hypothesised that NGF produced in the
periphery in response to inflammation is retrogradley transported to the cell bodies of
sensory nerves and mediates plastic changes in sensory neuropeptide expression.
However, the speed of observed changes in neuropeptide encoding mRNAs in these
experiments suggests they are too swift to be dependent upon axonal transport of
NGF, measured at 13 mm/h in the rat sciatic nerve (Stockel et al 1975). Indeed the
fastest retrograde transport of molecules in the sciatic nerve has been measured at
17mm/h (Ochs 1972), making it unlikely that the initial increases in PPPT-A and oc-
CGRP encoding mRNAs are mediated by the transport of any molecule from the
periphery. Additionally the distribution of high affinity NGF receptor (trkA) in DRG
neurones (as discussed in section 1.13) does not exactly match the neurones in which
increases in PPPT-A and a-CGRP encoding transcripts are seen, for example trk A
mRNA is not co-localised with PPT-A mRNA in large diameter neurones (Kashiba
et al 1996). Given the recent discovery that the low affinity neurotrophin factor
receptor p75 can activate signalling mechanisms independent of high affinity trk
receptors (Carter et al 1996), the distribution of p75, in relation to neuropeptide
encoding mRNAs may be of interest. However NGF is extremely unlikely to be
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involved in the initial changes in neuropeptide gene expression seen within the first
hours but may have a role in modulating neuropeptide gene expression during the
latter stages of the inflammatory process.
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4 Plasticity of Nervous and Immune Systems During Acute
Joint Inflammation
4.1 Introduction
As discussed in chapter 1.2 the nervous system has been implicated in the
development of joint inflammation. This view is supported by results presented in
chapter 3, where increases in mRNAs of PPPT-A and a-CGRP encoding gene are
seen in small diameter DRG neurones (<20pm), which is the size of nerve associated
with transmission of nociceptive information, within 30 min of joint inflammation
induced by FCA. Previous experimental data has shown the increases in mRNAs of
pPPT-A and a-CGRP encoding gene seen in small diameter L5 DRG neurones
within 8h of FCA injection can be prevented by pre-administration of the local
anaestheic, lignocaine, around the sciatic nerve (Donaldson et al 1994). Taken
together with the observation that application of 40mM K+ to cultures of adult DRG
neurones causes an upregulation of PPT-A expression (Mulderry et al 1993 b) the
evidence suggests that neural activity is pivotal to plastic changes in the expression
of genes encoding neuropeptides.
It would therefore be relevant to investigate the neural activity of a nerve innervating
a joint immediately after FCA injection. The tibio-tarsal joint of the rat receives
sensory innervation from the tibial nerve, an anterior branch of the sciatic nerve
(Greene 1959). The knee-joint is innervated by an articular branch of the common
peroneal nerve, a nerve which is derived from the sciatic nerve. Thus the knee shares
a common sensory innervation with the tibio-tarsal joint, with cell bodies located in
the same DRG (L4-6) (Greene et al 1959). The effect of injection of FCA (100p.g,
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intra-articular) into the knee joint on the rate of neural discharge of small diameter
innervating sensory nerves was studied.
Blocking propagation of action potentials in the sciatic nerve with lignocaine can be
employed to determine whether any changes in neural activity underlie the increases
in neuropeptide encoding mRNAs in small diameter DRG neurones innervating a
tibio-tarsal joint within 30 min ofFCA induced inflammation.
FCA injection and other models of joint inflammation are associated with joint
swelling (oedema) and development of hyperalgesia, the exaggerated response to
mechanical, chemical and thermal stimuli previously perceived as innocuous
(Schaible and Grubb 1993, Donaldson et al 1993). Oedema formation, an early event
in inflammation (see chapter 1.6.1), can be measured by a variety of methods, the
most convenient being measurement of the joint circumference at various time points
after FCA injection. At the same time points development of mechanical
hyperalgesia can be measured in terms of pressure required to evoke reflex
withdrawal of the ipsilateral limb.
As described in 1.6.1 immune cell infiltration into the inflamed area occurs later in
the inflammatory process than oedema formation. This response is seen 14 days after
FCA injection into the tibio-tarsal joint (Donaldson et al 1993), a time point at which
there are signs of articular cartilage breakdown, proliferation of synovial tissue,
pannus formation and bone resorption. The progression of inflammation was
followed by monitoring the histological changes in the tibio-tarsal joint over the first
24h of inflammation induced by FCA injection.
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4.2 Results
4.2.1 Effect ofFCA injection on neural activity
As shown in figure 4.1, FCA injection into the knee joint, as described in 2.6.1
causes an increased frequency in action potentials in innervating fine diameter nerves
within 15 min, the discharge seen is similar to that observed after stimulation of
polymodal C-fibres by capsaicin, or mechanical stimulation of the joint capsule. This
increased activity was still evident 30 min after adjuvant injection, however by lh
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Figure 4.1 Changes in the frequency of action potentials in fine diameter sensory
nerves innervating the rat knee joint after FCA injection (lOOpl i.a.). Action
potentials defined as the response of polymodal C fibres to capsaicin and/or
mechanical stimulation of the joint capsule. n=5, *p<0.05 compared with recordings
taken from untreated animals prior to FCA injection (0.68+.27). At 30 min discharge
is still significantly above levels of untreated control animals (2.34±0.56), at 60 min
levels are still elevated but are not statistically different from controls (1.93±.0.51).
Values represent single units isolated from multiple unit recordings.
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4.2.2 Role of neural activity in plasticity in [3PPT-A and g-CGRP gene expression
Inflammation of the tibio-tarsal joint caused by FCA injection, as described in
section 2.1, has previously been seen to cause a substantial increase in both pPPT-A
and a-CGRP encoding mRNAs in small diameter DRG neurones within 30 min of
injection (see section 3.2.1). This effect was reaffirmed by these experiments,
however rats showing flaccid paralysis after mid thigh injection of lignocaine to the
sciatic nerve, applied without exposure of the nerve (see section 2.6.2), did not
display rapid increases in the levels of PPPT-A and a-CGRP encoding mRNAs in
response to FCA injection, (figures 4.2 and 4.3)
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control FCA FCA+LA
Figure 4.2 Effect of preadministration of lignocaine (2%) around the sciatic nerve on
the expression ofmRNAs encoding P-PPTA in L5 DRG 30 min after ipsilateral sub-
dermal injection of FCA. Values (mean+SEM) expressed as % untreated control,




Figure 4.3 Effect of preadministration of lignocaine (2%) around the sciatic nerve on
the expression ofmRNAs encoding a-CGRP in L5 DRG 30 min after ipsilateral sub-
dermal injection of FCA. Values (mean±SEM) expressed as % untreated control,
n=3-5. *p<0.05 compared with untreated control.
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4.2.3 Progression of inflammation, assessed as development of oedema and
mechanical hyperalgesia
Oedema formation was monitored by measurement of joint circumference over the
first 8h of FCA induced inflammation (as described in section 2.1). The
circumference of the injected joint increased by a significantly within 30 minutes of
adjuvant injection and carried on enlarging, so that by 8h the circumference was 48%
greater (figure 4.4). There was also a significant increase in the circumference of the
uninjected limb, although at all time points after adjuvant injection the injected limb
was always markedly and significantly larger. Uninjected rats, used as an absolute
control, also showed an increase in joint circumference with time. The latter two
observations may be a result of tissue damage caused by repeated measurements.
Mechanical hyperalgeisa, assessed by the pressure applied to the tibio-tarsal joint
required to evoke reflex withdrawal of the leg, also showed changes over the first 8h
of inflammation. The injected limb was withdrawn at a significantly lower pressure
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Figure 4.4 Circumference of ipsilateral and contralateral tibio-tarsal joints within 8h
of injection of FCA. Values are mean±SEM n=5. *p<0.05 ipsilateral compared with
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Figure 4.5 Pressure applied to tibio-tarsal joints required to evoke withdrawal of limb
in animals with FCA injected tibio-tarsal joint and those receiving no treatment.
Values are mean±SEM n=5. *p<0.05, injected compared with noninjected animals at
equivalent time points.
4.2.4 Changes of histology of tibio-tarsal joints after adjuvant injection
The changes in tibio-tarsal joint histology over the first 24h of FCA induced joint




4.10. Over this time period there were no signs of cartilage or bone breakdown,
proliferation of the synovial tissue, or pannus formation. Effects were limited to the
periarticular soft tissue surrounding the joint, where inflammatory cell infiltration
was noted at 8h (figure 4.8) and 24h (figure 4.9) after ipsilateral FCA injection. No
changes in the histology of the tibio-tarsal joint or surrounding soft tissue
contralateral to injection were apparent at the 24h time point.
Figure 4.6 Histological apperance ofcontrol (uninjected) rat tibio-tarsal joint









Figure 4.7 Histological apperance ofrat tibio-tarsal lh after ipsilateral injection ofFCA,
containing 150mgM.tubercubsis, showing no signs of inflammation ofthe joint or
surrounding periarticular soft tissue.
JS=joint space, C=cartilage, B=bone, S=synovial tissue, ENdense connective tissue eg
tendon, joint capsule, ligament, P=periartieular soft tissue
Figure 4.8 Histological apperance ofrat tibio-tarsal 8h after ipsilateral injection ofFCA,
containing 150mg M.tuberculosis, showing inflammatory cell infiltration ofperiarticular soft
tissue, but not the joint.
JS=joint space, Oeartilage, B=bone, S=synovial tissue, D=dense connective tissue eg
tendon, joint capsule, ligament, P=periarticular soft tissue, I=inflammatoiy cell infiltration
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Figure 4.9 Histological apperance ofrat tibio-tarsal 24h after ipsilateral injection ofFCA,
containing 150mg M.tuberculosis, showing inflammatory cell infiltration ofperiarticular soft
tissue, but not the joint.





Figure 4.10 Histological apperance ofrat tibio-tarsal 24h after contralateral injection ofFCA,
containing 150mg M.tuberculosis, showing no inflammatory cell infiltration ofperiarticular
soft tissue or the joint.
JS=joint space, C=eartilage, B=bone, S=synovial tissue, P=periarticular soft tissue
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4.3 Discussion
The increased frequency of action potentials, which are similar to those observed
after capsaicin application to polymodal C-fibres, implicate C-fibres in the early
neural response to FCA injection. Changes in neural activity in sensory nerves
innervating an inflamed joint have also been detected in the kaolin/carrageenan
model of joint inflammation in the cat knee joint. Investigators have reported that 4-
5h after injection there is an increase in the basal discharge of group III and IV
afferents (C and A8 fibres), and an increase in the number of units displaying resting
discharge (Coggeshall et al 1983).
The expression ofmRNAs encoding PPPT-A and a-CGRP in the cell bodies of small
diameter nerves, such as C-fibres also increases rapidly (30 min) after FCA injection.
This suggests that neural activity may underlie the induction in neuropeptide
expression, a hypothesis supported by the prevention of FCA induced increases in
mRNAs by blocking of nerve conduction with pre-administration of local
anaesthetic. Local anaesthetics block the conduction in small diameter unmyelinated
fibres first, and for the longest duration. In these experiments, only animals treated
with local anaesthetics which displayed complete motor paralysis were subsequently
injected with adjuvant. Thus in these animals the propagation of action potentials in
C-fibres, the frequency of which appear to be increased after FCA injection, are
definitely blocked as there is no conduction in larger motor neurones. As previously
stated depolarisation of cultures of DRG neurones by application of 40mM K+ causes
an increase in PPT-A mRNA expression (Mulderry et al 1993 b). However this
stimulus also increases VIP encoding mRNA in cultures, but the expression of
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mRNA encoding this neuropeptide is not increased in FCA induced joint
inflammation (Donaldson et al 1992). Elsewhere in the nervous system,
depolarisation of the hippocampus with the excitotoxin kainate causes an increase in
PPT-A expression in vivo (Brene et al 1992).
It should also be noted that local anaesthetics, such as lignocaine, also block axonal
transport, but the increases in PPPT-A and a-CGRP encoding mRNAs seen within
30 min of FCA injection are too swift to be reliant upon transport of substances from
the periphery, since the maximum rate of axonal transport in the rat sciatic nerve has
been measured at 17mm/h (Ochs 1972).
Inflammatory events, as assessed by development of oedema and mechanical
hyperalgesia, occur very rapidly after FCA injection and continue in a progressive
manner. The significant increases in the circumference of joints contralateral to
injection were also seen in uninjected animals, and may reflect local tissue damage
due to repeated measurements. The exaggerated response to mechanical stimuli will
cause a guarding of the limb, thus protecting the inflamed area from further
damaging stimuli.
In other models of joint and peripheral inflammation the two inflammatory
parameters of oedema formation and development of mechanical hyperalgesia have
also been noted to increase rapidly after induction of inflammation. Intraplantar
hindpaw injection of FCA, which like FCA injection around the tibio-tarsal joint
causes increases in PPT-A mRNA in innervating DRG within 6h (Leslie et al 1995),
has been shown to result in oedema formation and increased mechanical and thermal
hyperalgesia within 6h (Stucky et al 1993, Galeazza et al 1995, Safieh-Garabedian et
al 1995). Marked oedema of the paw occurs within 15 min of hindpaw inflammation
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due to injection of carrageenan as measured by paw weight (Gilligan et al 1994),
whilst the same stimulus, but at a higher dose, causes oedema formation within 4h as
measured by paw width (Iadarola and Draisci 1988).
The formation of oedema occurs at, or near, the site of injection, suggesting it may
be a consequence of the release of local inflammatory mediators. This hypothesis is
supported by the observation that rats lacking central innervation, due to sectioning
of the sciatic nerve, develop oedema similar to that seen in non-transected rats in
response to injection of the tibio-tarsal joint with M. butyricum (Ahmed et al 1995 b).
A number of these inflammatory mediators have also been proposed to sensitise
peripheral nerve terminals (see chapter 1.4), contributing to primary hyperalgesia.
Indeed sensitisation of group II, III and IV afferents (Ap, A8 and C fibres
respectively), in response to mechanical stimuli including previously unresponsive
group III and IV afferents has been reported within the first hour of joint
inflammation caused by injection of kaolin/carrageenan into the knee joint of the cat,
with further sensitisation 2-4h after injection (Schaible and Schmidt 1988).
It is unclear if the observed mechanical hyperalgesia involves secondary
hyperalgesia, due to sensitisation of the dorsal horn to peripheral input, a process
which is postulated to be mediated by CGRP and the tachykinins, SP and NKA (see
chapter 1.6.2) Depolarisation of peripheral sensory nerves by electrical stimulation
leads to SP and CGRP release into the dorsal horn of the spinal cord (Yaksh et al
1980, Klein et al 1990). Here it has been shown that FCA injection causes an
increase in action potentials in small diameter innervating nerves, most probably C-
fibres, which widely express SP, NKA and CGRP. Thus it is probable these
neuropeptides are released into the dorsal horn of the spinal cord very soon after
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FCA injection. Indeed in studies using intraplantar FCA injection, it has been
postulated that SP may be released into the dorsal horn of the rat within 6h of
inflammatory stimulus (Stucky et al 1993). However the origin of the SP released is
unclear; it may be derived from primary afferents, or neurones of descending or
intrinsic origin. The same applies to increases of SP release from slices of the spinal
dorsal horn taken from rats 3h after hindpaw carrageenan injection. However the
release of CGRP, which is solely derived from primary afferents also increased
(Garry et al 1992).
Elevated levels of NKA are detectable in dorsal horn of the cat spinal cord
immediately after inflammation induced by injection of kaolin and carrageenan into
the knee joint (Hope et al 1990). In the same model there is an increase in CGRP
release into the spinal cord and enhanced CGRP release in response to both
innocuous and noxious stimuli within the first hours of inflammation; the latter effect
is also seen in rats (Schaible et al 1994). Furthermore there is evidence of secondary
hyperalgesia in response to thermal stimuli in this model, with a decrease in paw
withdrawal latency in response to thermal stimuli within 4h and up to 24h after
kaolin/carrageenan injection into the rat knee joint (Sluka and Westlund 1993).
SP and NKA have been implicated in mediating vasodilation and increased vascular
permeability at the site of inflammation (see chapter 1.6.1), events which underlie
oedema formation. However mice lacking SP and NKA, due to a disrupted PPT-A
gene, show the same degree of oedema formation as wild type mice in the hindpaw 1
and 3 days after FCA injection (Cao et al 1988). This suggests oedema formation can
occur without SP or NKA, but it should be noted that these animals have normal
levels of CGRP, which is proposed to be the primary mediator of vasodilation, whilst
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other inflammatory mediators, such as bradykinin, histamine and 5-HT are known
increase vasodilation and permeability of the microvasculature (Rang and Dale
1991). PPT-A knockout mice also display increased thresholds to moderate and
intense noxious thermal and mechanical stimuli. This evidence implicates SP and
NKA in the transmission of specific window of stimuli, consistent with their high
level of distribution in small diameter nerve fibres associated with transmission of
high threshold stimuli.
In previous experiments performed in this laboratory the histology of tibio-tarsal
joints 14 days after injection of FCA containing 150pg M.tuberculosis showed
infiltration of the joint by inflammatory cells, synovial hyperplasia and oedema,
pannus formation and subchondral bone resorption. The development of these
pathological features was found to correlate with the increase in joint circumference
and mechanical hyperalgesia (Donaldson et al 1993). At time points up to 24h after
adjuvant injection none of these histopathological changes are apparent in the present
study. After 8h, infiltration of the periarticular soft tissue by inflammatory cells is
visible. At 24h the cellular infiltration is still limited to the soft tissue surrounding the
joint, suggesting that inflammation is limited to the site of injection up to 24h after
FCA administration. In agreement with the phases of inflammation discussed in
chapter 1.6.1, oedema formation and development of mechanical hyperalgesia are
apparent at time points before cellular infiltration. As discussed in section 1.6.1.4 SP,
NKA and CGRP have a number of chemotactic and proliferative effects on immune
cells, thus the release of these neuropeptides from sensory nerves at or near the site
of injection may contribute to the cellular infiltration noted after 8h.
These data indicate that changes observed in neuropeptide encoding gene expression
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after FCA injection are not dependent upon changes in the tibio-tarsal joint, thus at
this acute stage the model is better described as one of peripheral inflammation rather
than joint inflammation.
The maximum rate of axonal transport in the sciatic nerve has been measured at
17mm/h (Ochs 1972), most molecules are transported at a slower rate, including SP
which has been measured at 5-10mm/h (Brimijoin et al 1980, Harmar and Keen
1982). This rate of axonal transport dictates that newly synthesised SP will not reach
peripheral nerve terminals until very late time points in these experiments. However
newly synthesised SP will reach central sensory nerves at much earlier time points.
Given the proposed role of these three neuropeptides in both central and peripheral
processes underlying inflammation, the upregulation in their production will lead to
the augmentation of the inflammatory response to FCA application.
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5 Molecular Mechanisms Underlying Neuropeptide Gene
Expression
5.1 Introduction
The levels of sensory neuropeptides at nerve terminals are dependent upon the rates
of production, as well as axonal transport and breakdown by peptidases. Thus the
control of gene expression of neuropeptides in DRG of sensory nerves associated
with transmission of nociceptive information innervating inflamed and non-inflamed
joints is of considerable interest and relevance. In this chapter the molecular
mechanisms underlying the increased expression of the genes encoding pPPT-A and
the a-CGRP in L5 DRG following FCA induced joint inflammation are investigated.
A preliminary study has been carried out utilising antisense technology, with the
ultimate aim of using antisense oligonucleotides (AS-ON) in vivo to block the
increases in PPPT-A and a-CGRP expression in DRG and test their requirement in
the subsequent development of FCA induced joint inflammation. This preliminary
study examined the ability of a number of AS-ON to decrease CGRP and SP
expression in primary cultures of adult rat dorsal root ganglion neurones. Cultures of
adult rat dorsal root ganglia neurones have been shown to be independent ofNGF for
survival. Application of NGF to cultures of adult rat dorsal root ganglia neurones
induces the expression ofPPT-A and a-CGRP (Lindsay and Harmar 1989).
The results obtained from these experiments are detailed below, however they did
raise the possibility of the involvement of stress-activated transcription factors in the
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increases in SP and CGRP. I have previously shown increases in neuropeptide
encoding mRNAs occur very rapidly, within 30 min, of FCA injection. These
increases are not prevented by prior treatment with cycloheximide and so are
unlikely to require protein synthesis. This would seem to preclude the involvement of
immediate early genes in the increases in PPPT-A and a-CGRP gene expression.
Similarly, the rapid time course of these increases suggest the involvement of post-
translational modification of pre-existing transcription factors. I have concentrated
investigations on 2 families of transcription factors, the Rel, including NFkB, and
STAT families. Members of both these families are expressed in nervous tissue, are
modified by post-translational modification and are implicated in modulating
stressful stimuli. These families are discussed in chapter 1.15 and 1.16.
The breakdown of IkB, as an indicator ofNFkB activation, in DRG was studied with
a view of a possible involvement ofNF-kB in the upregulation of the expression of
these two neuropeptide encoding genes.
5.1.1 Use of antisense oligonucleotides to specifically inhibit gene expression
Antisense oligonucleotides (AS-ON) are short synthetic single stranded nucleotide
sequences (<20 bases), which block synthesis of specific proteins, reviewed in
Hunter et al 1995. The AS-ON can be made up of bases found in RNA or DNA. AS-
ON are readily taken up into cells by an, as yet, unknown mechanism, despite their
large size (for example 17 bp AS-ONs used in these experiments have molecular
weights between 5 and 5.5 kDa) and negative charge. Once the AS-ON has entered
the cell it is predicted to bind to the target mRNA (or hnRNA), forming a double-
stranded nucleic acid species and subsequently blocking protein synthesis. The
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mechanisms for this are unclear, but are speculated to be due to:
1Recognition and degradation of the double stranded nucleic acid by RNase
H, an endogenous nuclease which may normally serve a protective role in infection
by selectively degrading viral dsRNA.
and/or 2)Prevention of the movement of the ribosome along the mRNA, causing
blockage of translation
Based on previous experiments there are a number of basic rules to follow in the
design ofAS-ON to ensure efficacy.
i)Choice ofNucleotide
The naturally occurring nucleotide bases have been used effectively in antisense
oligonucleotides, however their phosphodiester backbone is susceptible to
degradation by endogenous cellular enzymes, notably RNase H. This cellular
breakdown reduces their life span and thus their efficacy. By modifying the
nucleotide it is possible to make more stable backbones. The most stable
modifications have been achieved using phosphorothioate nucleotides.
ii) Length
The oligonucleotide must be small enough to be readily taken up by the cell, but
must be of a sufficient length to attain specific sequence interaction. A length of 15-
20 bases has been found to be optimal.
iii) G:C Content and Sequence Motifs to Avoid
Oligonucleotides with a high G:C content have been found to be 'sticky', binding to
RNA in a non-specific fashion. However if G:C content is too low the affinity of the
oligonucleotide is reduced. Sequences with a GCT core and GGGG motifs should be
avoided, as they are known to cause non-specific interactions (Hunter et al 1995).
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iv)01igonucleotide Target
In general, most success has been obtained when the sequence around the
translational start point (ATG) of the gene has been selected as the target.
Alternatively intron/exon boundaries have proved to be a fruitful target.
5.1.2 Transcription factors and the expression of neuropeptides
In chapter 3 I demonstrated that within 30 min of FCA injection expression of the
genes encoding SP and NKA, and CGRP is increased by a mechanism which is
independent of de-novo protein synthesis. Previous studies have shown that PPT-A
expression can be regulated by a wide variety of stimuli (see section 1.8), it has been
suggested that these stimuli may act at the level of transcription (Paterson et al 1995
a).
As described in section 1.8, a number of sites capable of binding transcription factors
have been identified in areas of PPT-A which can direct expression of a reporter
gene micro-injected into primary cultures ofDRG neurones. Located in this region of
the rat PPT-A gene are sites which interact with AP-1 (Paterson et al 1995a,
Morrison et al 1995), octamer binding protein (Mendelson et al 1998), members of
the bHLH (E box) family (Mendelson and Quinn 1995, Paterson et al 1995 a,b and c)
and the Sp 1 family (Quinn et al 1995, Mendelson et al 1998). Interestingly within
the enhancer regions active binding sites for octamer binding proteins and members
of the Sp 1 and NFkB families have been identified (Quinn et al 1995, Fiskerstrand
et al 1997, Mendelson et al 1998).
The immediate early genes from the Fos/ Jun family are unlikely to be involved in
the observed increases in PPPT-A and a-CGRP mRNAs. Members of the Fos/Jun
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family are either not expressed DRG neurones, or show no changes in mRNA levels
after FCA injection (Donaldson et al 1995 b). The time course of the increases in
neuropeptide expression is too rapid to be dependent on de novo protein synthesis (a
hypothesis supported by experiments involving the inhibitor of protein synthesis,
cycloheximide, presented in Chapter 3). In the case of the other proposed modulators
of PPT-A expression detailed above, although not immediate early genes, they are
not known to be rapidly modified post-translationally following activation of
intracellular signalling pathways by stressful stimuli. Therefore it is unlikely that
they are involved in the observed increases in either PPPT-A or a-CGRP mRNAs.
A number of transcription factors are known to be held as complexes in the
cytoplasm, where they cannot modulate gene expression. Phosphorylation of the
cytoplasmic transcription factor complex causes a conformational change revealing a
nuclear localisation signal. This directs translocation of the transcription factor to the
nucleus, where it can bind at specific DNA motifs and modulate gene expression.
Transcription factors of this class are reviewed by Jans (1995) and include the
nuclear factor k B (NFkB) family and signal transducers and activators of
transcription (STAT).
5.2 Results
5.2.1 Effect of application ofAS-ON to sensory nerve cell culture to levels of SP and
CGRP
Following the design criteria outlined in section 5.1.1 phosphorothioate
oligonucleotides complementary to short regions of sequences of P-PPTA and a-
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CGRP mRNAs were synthesised (Oswel UK). These sequences are described in
Table 5.1.
PPTATG 5'ATT TTC ATG TTG GAT TT 3'
PPT Exon 2 5'CAA TAA TTT AGA TCA TC 3'
CGRP ATG 5'TTC AGA AAG CCC ATG AT 3'
Scramble 5' GTT ATC TTT GTA TGT AT 3'
Table 5.1 Base sequences of phosphorothioate antisense oligonucleotide applied to
cultures of adult dorsal root ganglia
Primary cultures of DRG neurones were treated with AS-ONs at two doses, 500nm
and 2.5pm. Scramble sequences were used to examine the number of non-specific
effects associated with AS-ON. They contain a similar proportion of constituent
bases as targeted oligonucleotides, but in a randomised/scrambled order, so will not
hybridise with the gene of interest. The CGRP ATG AS-ON acts as an additional
scramble when measuring SP, and likewise the two PPT related oligonucleotides act
as scramble sequences when measuring CGRP. The results of AS-ON application on
CGRP levels in cultures of DRG neurones are illustrated in figure 5.1. Contrary to
expectations, all the oligonucleotides at the higher dose increased CGRP production
by DRG neurones with a similar magnitude of effect. At the lower dose, only the
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control CGRP ATG Scramble PPT ATG PPT Exon 2
Figure 5.1 Effect of application of phosphorothioate antisense oligonucleotides, at
different doses on concentration of CGRP found in cultures of adult DRG neurons.
Controls represent levels in untreated cultures. Values are mean±SEM, n=4. Data
analysed by ANOVA followed by Dunnett's post hoc test. The Null hypothesis was
rejected at P<0.05.
The effect of AS-ON application on SP production in cultures of DRG neurones is
illustrated in figure 5.2. Statistical analysis of this data was not possible as levels of
SP in some samples were below the detection limit for the SP RIA (400 pg/ml).
However there was a dose dependent trend, where higher levels of SP were found in












Control CGRPATG PPTATG PPTExon2 Scramble
Figure 5.2 Effect of application of phosphorothioate antisense oligonucleotides, at 2
different doses, on production of SP by adult DRG neurones. Experiments conducted
in 4 cultures per group, but some levels below detection limit of the assay (400pg) so
not included in graph. ND= no data (all values below 400pg), CGRP ATG 2.5pM
n=4; PPT ATG 500nM n=2, 2.5pM n=2; PPT Exon2 500nM n=3, 2.5pM n=3;
Scramble 500nM n=l, 2.5pM n=4.
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5.2.2 Identification of putative transcription factor binding sites in the promoter
regions of rat BPPT-A and the a-CGRP encoding gene
The sequence of the promoter regions of both these genes were obtained from the
MRC HGMP database. The pPPT-A promoter, spanning bases -3355=>+893 relative
to the transcriptional start point (accession number L07328), and the a-CGRP
promoter, spanning bases -1366=>+3 relative to the transcriptional start point
(accession number M34090), were analysed for the consensus sequences of GAS,
ISRE and NFkB binding sites (see 1.14 and 1.15) using Gene Jockey II sequence
processor computer software (Biosoft, UK). The results are displayed in figure 5.3
(pPPT-A) and figure 5.4 (a-CGRP).
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-3356GGATCCTGCTCTCCCTGGGAGTAATTTCTCflAAGCAAACTATTTTGTTCTACAA G TTGGTTTTTCACTT GTAGAGTA TGTAG AAAATGATCTGA -3256TGACTTrrrCTCTAAAGTTGTAAGCAGTATAAAAAGCTTTAAAGTGACTTATG TC GTCACATGAAAAT GACAAT CA CAGITTAGriTTC ITTT -3156TAAGGTATATGTTTTTTATTATTCATGTATAAATGTTTTGCATGTGTTTATGTGTAGACC GT C GA GC C C AAAGGACA AAGAGGGCAGCA -3056GATCCCCTGGATTATAGATTACGAATGGTTGCCAGCTACTACATGGGTGCTGG A C A CCC CATCTTTA CAAGAGCAACAAGT CTTTAAC CCT -2956GAGCTATCTGCCCAGTCCCTCTTTATAATTTTCTACGGATAATTAATTGGCAAAAATGAAAATATGA ACT TG CA C TCTTGTTCC A AACTT -2856AGTATGCATCAGGAACACTTGTATTTTATTAAGATTTGTATTTTAAACATCTGAGGAA TGCA AATTAG A CAAATATCTTCAGTCCTGCTATGT -2756TCAAGAAAAACATGAGTCAGAAAGTATATGAAATTACTAAGAAAATTAAGGAGTATT A TGATGGTCCTGGGCA GTGGGAAGTT GTTGGGTACTAAC -2656ATTGACTGACCTTTGGTTAAGATCTCTAAGCAGACAGCATCACAACTATTAGGACACATTCAAG GAAAGAGGAAGTGATTGGArCAA G ACCAGAAA -2556ACAACTCTGAGTGAGAGCCTGCTGCTTTGCAAAACAACCTCTCCCAAGAACTAAGCA AGT CACAAAAACTATGCC AC T TC AAAGCCTGCAC -2456CCTGATGACTGCTATACCAACACTAGAATGTCTCCATTAGATGTCTGGCAACTTATCAAC TGGC ACATT ATGACTAAGTG GC GTC AT A CTGA -2356GGGGAAACAAACCACATTCAATCTCCAGCAAAAGGAAAATGTTTAGCAGAGG GAG AGGAA A GAGGC TG CT TGGTCC TTTA T TATT -2256ATTATTAAAGATTAACATATATATATGATTAAAGATTGCCTTTTAGAGTTG TC TATTATAT AC G AGATTAA TTAAAAACAA ATA ATTTA -2156AAAGCAAAATGATCAAATAAGGTTTGGCACCATAACTACTTACAGACATTTT AT ATTTTTA GAAG GA GTA C TAAGTGAACATACCT CAG -2056TGTTATGCCCCTAAAGTCAGAAAAAATGCAAAAAAAAAAACCCTATTATCTAATT AAC T AATTGTTGAGCATGTTG C TTG GTGAG GGCCAT -1956GTGAATGATATGACTGGCAAGTGGGAATTTTGGTATTGAAAGTGTCATGAAATATACTAG TTA TAAAAGCCATGATATTCCGATT T AGAAAGTG -1856TCCACATGTTTGTGATTTTATATACTACACACACACAGAACATTAACACATAC AT CG ACACAGACACATT T T TCTCTCT TC CT T TCTCT -1756CTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCCAGCACCATGCATTACCTTGAAGCAATGAAAATGAAAATGACTC TG AGTCTTTCGTAGGAA -1656ACATCAAAACCAAGAGAACCATCAATTCCTGTCAAAGGCCTTGGAAGAATCTTCTGAT GCCAGGAATGGC AAG TGAGC TCAGTTAAAG T CT -1556TCCTTGCACTGAAATGTTAAATCTGTGAGGTTCTAGTCTTAAAAAAGCAGGTCATACTT AAAGTGC AAA TAGT A T TTAAAGTTAGTAGAGGGA -1456AGAAATCAGGGATTTAGCTCATATTTCCTGAATTATGTATCAGAATAACTA CA TGCAT AGA A A TTTCT TGT A GGAATCC G AATTGA -1356CAAATTGTTTTAGGCGAATGACTCTACATTTGTGTTCACAATTTCTTCTTTTAA GGTTTTGA ATTAAAAATAGAA TCAG TTATGAAA CATC -1256TGAATGTCTACATTCAGAAATAAAAACAATAAACATTGGAGGCGAACATCAGT TGGCTCAC C CTTCTTTCCTCTTCAAATTATACT ACATAGT -1156GGGAAACTATGATTCCCCAAGGAAAACAACTCTATCCAAATGACAGCATCCT G TGGTGGTCCAC CCTGT G TCCAGTCCTGAGTAGGCGGAGT -1056CAGGAGGATACCCAGTTTGAAGCCACATAATGAGACTTAGTAATAATAATAATAATAAT A AATAATAAT ATAATAAT ATAA C C TC C TA -956CTTCATCAAAAGATGGAAAAGAATTATACAGTGGGGACAGAAGGCATCTGTA CC TTTGTAAATGACTTCTGTCTCTGACAGATCTGCAGAGCT -856CCAAAGGTAAGCATCCAGCCTTTCTAGTCCCCCAACAAGGCTAAAGGGGAAG G CAATTATCCT TTCCCACC TT TGCCTTCAG TGTGCCT -756GGGAAGAAGCTGTAGGGGAACAAAAGATGCCTTAGAATGGCTGATGGGTAAGTTCTACAT A A AGG GGTTTAAAT CCTCT TCCCCT AAT AA -656ACAAACCTGCCTTCATCCTCTGAAGCGGGAGACCGGAAACACTTTTGCAGTGCTAGAGA ATGAGAAT TTCT ACTGATTT GTGGGGAGG GG TTGG -56GGGGGTGTGTTCCAGCCCTAGATATAACACCTCATAAACCTTAAGACACATAAAGTAGAAAT AAAGGA A CCC GCT GC TC T CCTCTGA GTGC -456TTGCTGGTGTCTTAGTATTATTCACAAGGTTTTGCTGCTCAAGTTATTTGGCTGTCCTCAAAGCGCAAT TTCCCTGA GC CT G GAGA AAGTTCC -356CTAAGTCCGAAGCATGAGTCACTTCGCTCAGTTTTGATGAGTAATCTCAGTGTCACT A CCTTGTTCGGAAGAAGAGGGGAGGGGGGCGTCAGATTTG -256CAGACGGAAGAAAACAGGTCTCTCTGGATTGGATGGCGAGACCTCGACrrCC TAA TTGCGTCATT GAA CCA TGGTCCAGAT TTATGGACT -156CCGACGGGTTACCGTCTCGGAAACTCTATCACGCAAGCAAAAGGCGAGGGGGC CTAATTAAATATTG G AGA AGT GT GGG GA T TCACGT -56GGCTCTCCAGGCTCATCACGCCTGAGATAAATAAGGCGAAGCAGGAGCAGGGACT AGCGCA T GACC C CC CTCCAGCACCGC GCGGAGGAG +44AGCGAGGAGCGCCCAGCAAGTGCGCACCTGCGGAGCATCACCGGGTCCGACC C T AGTACCACTCCCGC TG CATCTGCCGCTGCCT G CGT +144CGTGCCTTGGTCAGAGGTGGCGTCCGCCCGGGGTTTCACCTGCAGCAGCCA AGACCCGGAGA AAA TGTGCAAATACCAACACCTCTCTTT TCT 127
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5.2.3 IkB-cc in L5 of untreated and inflamed animals
Animals received an ipsilateral intradermal injection of FCA around the joint (as
described in chapter 2.1) 30 min. before sacrifice. IkB expression in protein extracts
from L5 DRG ipsilateral and contralateral to the injected limb was examined by
western analysis.
The antibody used in these experiments was specific for IkB, displaying no cross-
reactivity to recombinant p65 (figure 5.5). Bands detected in DRG extracts were of a
similar mobility to recombinant IkB-cc, with an approximate molecular weight of
40kDa. The Mw of IkB-oc is cited as 37 kDa (Israel 1995), therefore it seems likely
that IkB-cc is present in all DRG samples.
As shown in figure 5.5, there is no decrease in intensity of IkB-cc bands taken from
untreated DRG or those from animals 30 min after FCA injection, indeed there
appears to be a slight increase in band intensity. Thus it would appear from these
experimental results that degradation of IkB-oc is not apparent in DRG 30 min after
adjuvant administration.
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Figure 5.5 Western blots using an antibody specific for IkB-cc and extracts from L5
dorsal root ganglia from rats treated as follows;
Lane 1 Untreated animal
Lane 2 30 min after contralateral FCA injection
Lane 3 30 min after ipsilateral FCA injection
Lane 4 30 min after ipsilateral FCA injection
Lane 5 Recombinant p65 (negative control)
Lane 6 Recombinant IkB-oc (positive control)
5.2.4 Analysis of STAT gene expression in DRG by PCR
To analyse STAT gene expression in DRG, degenerate primers, designed to amplify
STAT 1,3 and 4 (C. Watson, personal communication) were used in RT-PCR
experiments lpg of total RNA isolated from L5 DRG and liver were reversed
transcribed. Resulting cDNAs were separately subjected to 30 cycles of PCR (section
2.11) using STAT primers or primers designed to amplify (3-actin, as a positive
control. Primers designed to amplify p-actin produced the predicted 550 bp product
in both DRG and liver samples (figure 5.6). This demonstrated that cDNAs had been
successfully produced by reverse transcription.
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Mw DRG Liver
Figure 5.6 Bands representing specific polymerase chain reaction products from p-
actin primers and cDNA from dorsal root ganglia (DRG) and liver. Bands in the lane
labelled Mw represent molecular weight markers (1Kb Ladder, Gibco BRL), sizes in
base pairs are given to the left of the image.
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The degenerate STAT primers produced a single DNA fragment in both liver and





Figure 5.7 Bands representing specific polymerase chain reaction products from
degenerate primers for the SH-2 domain of STAT 1,3,4 and cDNA from dorsal root
ganglia (DRG) and liver. The bands in the lane marked Mw represent molecular
weight markers (1KB Plus Ladder, Gibco BRL), sizes are given in base pairs on the
left of the image. The two lanes marked DRG and Liver are taken from a single
reaction
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The PCR product generated was subcloned (chapter 2.11) to allow partial DNA
sequencing of this product, detailed in table 5.3. The sequencing was performed by
Val Lyons.
1 GGGCTGCTGG TCCTTGAGCA GAGCACGTTC TCGCTCCTTG CTGATAAAGC
51 CCATGATGCA CCCATCATTC CAGAGGCAAA GCAGGTGCTT CTTAATGAGT
101 TCTAGGATGG TGTCAATCCA AGGCTAGAAG GAGAAATTCT TATCGTTAAT
151 ATTTTCCTTA CAGAACCTTG TCCATGGAAT AAGACCATCA GGGCCA
Table 5.3 Nucleotide sequence of PCR product produced from DRG derived cDNA
and STAT primers
The nucleotide sequence obtained was used to search for similar DNA sequences in
the Genbank and EMBL databases. The results are presented in table 5.4.
Member Species Base Matches
(% identity)
Accession Nun
STAT 1 Mouse 184/195 (94) U06924
Human 152/175 (89) M97936
STAT 2 Pig 62/92 (67) AB004061
Human 51/79 (64) U18671
STAT 3 Rat 111/163 (68) X91810
STAT 4 Human 113/165 (68) L78440
STAT 5a Rat 91/157 (57) U24175
STAT 5b Mouse 84/144 (58) Z48538
Human 92/158 (58) U48730
STAT 6 Rat 82/142 (57) AF055292
Table 5.4 Results of the blast search of the PCR products produced from DRG cDNA
using degenerate primers for STAT 1, 3 and 4.
5.3 Discussion
Results from the AS-ON studies suggest that the phosphorothioates oligonucleotides
are having a 'stress effect' on cultured sensory neurones, causing a dose-related
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increase in production of SP and CGRP. In subsequent work utilising DRG cultures
Mulderry and Dobson demonstrate the inhibition of c-Jun expression by
microinjection of phosphorothioate oligonucleotides (Mulderry and Dobson 1996).
This was reported to not alter the number of cells immunopositive for SP, the effects
on total SP levels in DRG are unknown.
In experiments to elucidate the role of the low affinity neurotrophin receptor, p75, in
sensory nerve survival, phosphorothioate AS-ONs have been successfully employed
to decrease receptor number in cultures ofDRG neurones (Barrett and Bartlett 1994).
However unlike the experiments presented in this chapter, AS-ONs were mixed and
triturated with the cells immediately before plating. Furthermore these AS-ONs were
also effective in vivo, being retrogradely transported to DRG cell bodies after
application to the proximal stump of a transected peripheral nerve, and decreasing
the number of p75 immunopositive neurones (Cheema et al 1996). However, this
method would be unsuitable for the analysis of SP and CGRP after FCA induced
joint inflammation, as nerve transection itself causes a decrease in the expression of
SP and CGRP (Hokfelt et al 1994).
Phosphorothioate oligonucleotides, regardless of size, induce expression of the
transcription factor Spl in a wide variety of cell types, this induction was blocked by
inhibition of the NFkB (Perez et al 1994). Thus, phosphorothioate oligonucleotides
may stress the cells resulting in NFkB induction, which in turn increases the
expression of target genes. It is possible that such a mechanism may account for the
non-specific effects seen here.
A number of kinases have been implicated in IkB phosphorylation. These include
PKR (Kumar et al 1994), also referred to as double-stranded RNA activated protein
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kinase. As the name suggests the kinase is activated in the presence of double
stranded RNA (dsRNA) and phosphorylates serine and threonine residues (Meurs et
al 1990). dsRNA is found in virus molecules, and so PKR has been implicated in an
anti-viral role. However, the mode of action of antisense oligonucleotides is thought
to be dependent on the formation of double stranded species between interaction of
hnRNA or mRNA and the applied AS-ON, thus AS-ON could result in PKR
activation. PKR has also been shown to phosphorylate IkB-cc in vitro (Kumar et al
1994), thus potentially activating NFkB dimers bound to IkB-oc. The activation of
NFkB would then result in increased expression of genes with the ability to bind this
transcription factor.
The original aim of these experiments was to establish a method of selectively
decreasing SP or CGRP expression in DRG neurones and hence determine the
involvement of these neuropeptides in the aetiology of FCA induced inflammation.
Since these experiments were carried out the role of SP in inflammation and pain
transmission have in part been answered by studies using animals in which the PPT-
A gene or the gene encoding the NK-1 receptor had been disrupted. The validity of
results obtained from these knockout animals are discussed in section 1.14.
In view of the activation of NFkB by phosphorothioate oligonucleotides and the
increased production of SP and CGRP in cultures of DRG neurones treated with
phosphorothioate based AS-ONs the promoter regions of both PPPT-A and the gene
encoding a-CGRP were analysed for NFkB binding sites. A number of sequences
with limited homology to the consensus binding site for NFkB were found in the
promoter region of both genes, however it is not known if these sites are capable of
binding members of the NFkB family. Experiments utilising specific antibody
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showed that IkB-oc is present in DRG, although it is not clear from these data which
population of cells contain IkB-oc. The presence of ficB-a infers that members of the
NFkB family (p50 and p65 being the most likely) are probably also present in DRG.
The original aim of this experiment was to use the levels of IkB as an indication of
the activity ofNFkB. However IkB gene expression is positively regulated by NFkB
(Sun et al 1993), therefore NFkB activation leads to de novo IkB production,
replacing IkB degraded as described in figure 1.6. In previous experiments I have
shown that there are increases in DRG SP and CGRP levels within 30 min of FCA
injection. If expression of these peptides is regulated by NFkB it is likely that IkB
expression would also increase.
This indicates a limitation of this experiment, it would have been better to
investigated using electromobility shift assay (EMSA). This technique involves the
ability of protein extracted from nuclei to bind to a synthetic oligonucleotide of a
transcription factor binding site, and thus the activity of the transcription factor of
interest. However, because of logistical problem in the small amount of nuclear
protein obtainable from DRG and the relatively large amounts needed for EMSA
analysis, these experiments are technically difficult to perform in this model. IkB-a
is the commonest of the IkB family, however this experiment does not take into
account other members of the IkB family, which may be present in DRG cells and
play a role in NFkB activation.
Immunocytochemistry studies investigating the active form of the NFkB family
member, p65, reported this transcription factor to be found in all diameters of L4 and
5 DRG neurones (Doyle 1997). The highest distribution was in cells of small
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diameter, the size of neurone associated with transmission of nociceptive stimuli, and
with the highest distribution of cells expressing PPT and CGRP. Interestingly the
number of cells immunopositive for the activated form of p65 was greatly reduced
within 4h of sciatic nerve crush (Doyle and Hunt 1997), a condition that is also
associated with a decrease in SP synthesis (Nielsch et al 1987, Hokfelt et al 1994),
suggesting a possible role for NFkB in the regulation ofPPT.
A region within the PPT promoter, between bases +92 to +500 has been identified as
a major enhancer of promoter activity in DRG under basal conditions (Mulderry et al
1993 a). This area shows a large degree of homology with an area 5' of the
transcriptional start point between bases -700 and -500, which also has enhancer
activity. These two similar areas contain an AT rich region which can be bound by
members of the NFkB family and also members of the octamer binding protein
family as demonstrated by EMSA analysis (Fiskerstrand et al 1997). These
experiments were conducted in vitro, therefore it is difficult to draw definitive
conclusions about their role in vivo. However NFkB binding has been reported in
DRG extracts 6h after inflammation induced by intraplantar injection of TNF-a
(Wood 1995). The AT rich regions to which NFkB are proposed to bind to in the
PPT gene, show little conservation to the consensus sequence of NFkB
(GGGAa/cTNt/cCC), which may indicate a novel binding site for NFkB.
Injection of FCA causes an increase in neural activity over a similar time course to
the increases in PPPT-A and a-CGRP mRNA expression. Increased expression of
both these neuropeptide mRNAs is prevented by local anaesthetics (Chapter 4).
These results suggest that depolarisation of DRG neurones may underlie increases in
neuropeptide encoding mRNAs. Depolarisation in hippocampus by kainate
138
application causes NFkB induction (Unlap and Jope 1995) and also PPT-A
expression (Brene et al 1992).
Taken together these data are inconclusive as to a role of NFkB in the upregulation
of expression of genes encoding the sensory neuropeptides SP, NKA and CGRP
caused by FCA induced joint inflammation. However there is enough circumstantial
evidence to suggest it may be a fruitful avenue of further investigation.
Using RT-PCR the existence of mRNA encoding STAT 1, or a STAT 1 -like
molecule, in adult rat L5 DRG has been demonstrated. The form and cellular
distribution of STAT 1 in DRG is unresolved, these questions could be addressed by
immunocytochemistry. STAT 1 binds to DNA sequences similar to GAS, but not at
ISREs. Analysis of the promoter region of both PPPT-A and the a-CGRP encoding
gene reveals there are numerous putative GAS sequences in both genes, especially
PPPT-A. However it is not clear if these sites are transcriptionally active, with the
ability to bind STAT proteins The putative GAS sequence spanning bases -671 =>-
663 of the PPT promoter is of particular interest as it lies within a region identified as
an enhancer element by in vitro studies (Mulderry et al 1993 a). In addition there are
sequences showing limited homology to ISREs in promoters of both neuropeptide
encoding genes. It is possible that other STAT proteins are present in DRG.
Previous experiments have shown a number of cytokines and chemokines, which can
signal via STAT proteins affect SP and CGRP expression in cultured sympathetic
neurones (Freidin and Kessler 1991, Fann and Patterson 1994). One of these
cytokines is interleukin (IL-6). The interleukin 6 receptor (IL-6R) has been located in
DRG neurones of all sizes (Gadient and Otten 1996), and belong to a family of
receptors which contain a common subunit, termed gpl30 (Hirano et al 1994).
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Receptors containing the gpl30 subunit can signal via the Jak/STAT pathway and
binding of IL-6 to its receptor causes STAT 1 translocation to the nucleus (Akira et
al 1994). Leukaemia inhibitory factor (LIF) is one of the identified chemokines
which causes an increase in neuropeptide expression in cultures of sympathetic
neurones (Freidin and Kessler 1991, Fann and Patterson 1994). LIF receptors are
also members of the gpl30 receptor family and are thus capable of activating the
Jak/STAT pathway (Hirano et al 1994). The effect of LIF on neuropeptide gene
expression in DRG is unclear. LIF failed to alter SP or CGRP levels when applied to
cultures of DRG neurones (Mulderry 1994), but reverses the decrease in SP-
encoding mRNA in DRG caused by axotomy of the sciatic nerve, although only
when applied at high dose (Zhang et al 1995). Upon intraneural injection into the
sciatic nerve LIF is retrogradely transported exclusively to small diameter neurones,
where it is co-localised with CGRP, and the high-affinity NGF receptor, trkA
(Thompson et al 1997). However the observation that LIF increases during nerve
injury (Banner and Patterson 1994) and that injection of LIF into the sciatic nerve
and nerve transection induce galanin expression in similar populations L4 and 5
DRG neurones (Thompson et al 1998), have implicated LIF in axotomy, a condition
associated with a decrease in SP levels in the DRG (Nielsch et al 1987, Hokfelt et al
1994).
LIF is hard to detect in the adult DRG under basal conditions (Murphy et al 1993),
suggesting it is only expressed under specific conditions, this and the proposal that
LIF is axonally transported from the periphery in the same manner as NGF
(Thompson et al 1997), means it is not well placed to play a role in rapid plastic
changes in DRG following peripheral inflammation.
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5.4 Future Perspectives
Experimental data presented in this chapter have only scratched the surface of the
possible molecular mechanisms underlying the FCA-induced increases in pPPT-A
and a-CGRP encoding mRNAs. The class of transcription factors responsible for
mediating such swift upregulation in the expression of pPPT-A and a-CGRP
mRNAs are likely to be factors which exist in a labile state in the cytoplasm, and are
rapidly translocated to the nucleus following phosphorylation at specific residues.
The translocation of factors from the cytoplasm to the nucleus of L5 DRG neurones
after FCA induced joint inflammation could be visualised using
immunocytochemistry. However this approach would not identify the genes that
were modulated by the transcription factors. Performing immunocytochemistry for
transcription factors and in-situ hybridisation for mRNAs encoding sensory
neuropeptides on the same or serial DRG sections may uncover a link between
transcription factor translocation and gene induction.
Protein-DNA interactions, such as transcription factor binding, can be studied using a
number of techniques including EMSA or DNAse 1 protection analysis. These
techniques rely on the specific interaction between DNA (either fragments or
synthetic oligonucleotides) and nuclear extracts derived from the tissue of interest.
Theoretically nuclear extracts taken from L5 DRG at specific time points after FCA
induced joint inflammation could be used. However with the technical difficulty of
obtaining sufficient nuclear protein from rat L5 DRG to use in these kinds of
experiments, this approach is likely to be of limited use. Higher yields of nuclear
protein could be extracted from the DRG of larger animals, for example sheep.
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However this would require the development of a FCA induced model of joint
inflammation in the sheep which shows similar aetiology as the unilateral model
developed in the rat.
Alternatively, the possible signalling mechanism induced by FCA could be the target
of future experiments. Activation of signalling pathways is associated with
phosphorylation of signalling components at specific residues. Antibodies which
recognise the phosphorylated forms of signalling molecules could be used to gauge
the activation of pathways in DRG neurones which show increases in PPPT-A and
a-CGRP encoding mRNAs after FCA treatment, using immunocytochemistry and
in-situ hybridisation. Phosphorylation generally occurs on serine, threonine or
tyrosine residues, antibodies which recognise phosphorylated forms of these amino
acids are readily available. These could be used in western blots to identify
phosphorylated proteins by size if no antibodies were available specific for the
phosphorylated form of a signalling molecule. Additionally, the antibodies which
recognise phosphorylated forms of these three amino acid residues can be used to
immunoprecipitate proteins phosphorylated in response to FCA induced joint
inflammation. Western blots could then be carried out on immunoprecipitated
proteins to identify putative signalling molecules.
Given that neural activity appears to be pivotal to the increases in PPPT-A and a-
CGRP gene expression, the elucidation of the pathway underlying the depolarisation
induced increases in PPT expression observed in cultures of primary sensory
neurones (Mulderry et al 1993 b) would be of interest and relevance.
Studying the aetiology and plasticity in sensory neuropeptide expression following
FCA induced joint inflammation in animals lacking specific transcription factors
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may seem an attractive method of screening for potential mediators in the
upregulation of PPPT-A and a-CGRP. However many transcription factors are
widely expressed and play roles in development or in cellular processes in adult
animals. For instance mice which lack STAT 2 or 3 die at the embryonic stage,
whilst mice lacking STAT 4 or 6 have an impaired immune system (Darnell 1997).
If the loss of gene expression were more localised it may give a better idea of the
potential involvement of various molecules in joint inflammation induced increases
in neuropeptide encoding genes in encoding DRG. Once the problems of toxicity and
effective delivery to the DRG have been overcome, AS-ON would be an ideal tool
for attaining a localised block of the expression of specific genes.
With the identification of the pathway/transcription factor responsible for the
increased expression of pPPT-A and the a-CGRP encoding gene it may be possible
to devise a strategy for blocking this increase using specific inhibitors. Given the
proposed role of the sensory neuropeptides in transmission of nociceptive
information, development of hyperalgesia and neurogenic inflammation, this could




Based on the results presented it seems the following sequence of events occurs in
response to FCA-induced inflammation.
Injection of FCA around the tibio-tarsal joint causes rapid inflammation, as seen by
the formation of odema and development ofmechanical hyperalgesia with 30 min of
injection. Within 15min of FCA injection into a joint there is an increase in the
neural activity of innervating small diameter sensory nerves. As detailed in section
1.4, a number of mediators released in response to inflammation, caused by FCA
injection, can excite or sensitise sensory nerves.
Within 30 min of FCA injection around the tibio-tarsal joint there are increases in
mRNAs encoding (3PPT-A and a-CGRP in innervating L5 DRG. These increases are
prevented by prior administration of the local anaesthetic lignocaine around the
sciatic nerve innervating the joint to be injected with FCA. Increased pPPT-A
hnRNA levels 30 min after FCA injection indicate that the initial increase in |3PPT-A
mRNA is in part attributable to de novo gene expression. Taken together these results
suggest that an increase in sensory neural activity causes increases in the expression
of neuropeptide encoding genes in L5 DRG. These rapid changes in gene expression
are too fast to be due to retrograde axonal transport of a molecule such as NGF from
the periphery, or the de novo protein synthesis of a transcription factor. The latter
hypothesis is supported by the observation that systemic injection of the protein
synthesis inhibitor cycloheximide does not prevent FCA-induced increases in a-
CGRP encoding mRNA. This evidence suggests that AP-2, which has previously
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been implicated in playing a role in regulating an increase in both (3PPT-A and a-
CGRP encoding genes (Donaldson et al 1995 b), is not involved in the initial
upregulation of these two genes.
The speed of increases in pPPT-A and a-CGRP encoding mRNA dictate that the
increases in the expression of these genes are likely to be mediated by activation of a
transcriptional modulator by post-translational modification, such as
phosphorylation. Such a modification may be due to induction of a kinase cascade in
response to the increased neural activity, and associated depolarisation of DRG
neurones, activating a cell surface mechanism (receptor, voltage-gated ion channel).
A number of transcription factors are activated by phosphorylation (as reviewed by
Jans 1995), these include members of the NFkB and STAT families. Analysis of the
promoter regions of PPPT-A and a-CGRP encoding genes has found sequences
showing homology to binding sites for members of both families. Other
experimenters have identified two sequences within enhancer elements of the PPPT-
A promoter which are capable of binding NFkB (Fiskerstrand et al 1997). Further
investigations in this thesis have shown that members of the NFkB family and STAT
1 are present in DRG. Collectively these data suggest that members of the NFkB
family and Stat 1 may be putative regulators of the rapid increases in the expression
of the PPPT-A and a-CGRP encoding genes seen in response to FCA injection.
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